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 Abstract 
 
Aging is a complex process that is associated with changes in many parts of the body 
over the lifespan of an individual. In this work, various aspects of aging in the human 
bone marrow were investigated.  
As the regenerative power of a tissue is linked to the potential of its stem cells to 
replace the accumulated damages, the aging process in somatic stem cells was 
studied focusing on the influence of the niche in regulating stem cell aging. The 
hematopoietic stem cells (HSC) together with elements that constitute the bone 
marrow niche were investigated as a model for somatic stem cell aging as HSCs are 
accessible in healthy human individuals. The subjects ranged from 20 to 60 years 
with a median age of 33.2 years.  
From each bone marrow sample, the CD34+ population as HSCs and four other cell 
subpopulations, lymphocytes and precursors (LYM), monocytes/macrophages 
precursors (MON), granulocytic (GRA), and erythroid precursors (ERP) were isolated 
by flow cytometry. The mesenchymal stromal cells (MSC) were isolated by in vitro 
culture. We found that the relative proportions, cell size as well as cell granularity of 
the major bone marrow constituents did not correlate with the biological age of the 
donors. However, further downstream analysis indicated that age-associated 
changes were prominent on protein level in HSCs as well as in other cell types of the 
niche such as MSCs.  
The interactions between the HSCs and the niche were studied in vitro using a co-
culture system of CD34+ cells and mesenchymal stromal cells (MSC). As previous 
studies indicated that the supportive function of MSCs as well as their differentiation 
potentials towards adipocytes and osteocytes change significantly with age, we have 
examined the supportive ability of the undifferentiated MSCs versus adipogenically 
differentiated MSCs (ADI-MSCs) and osteogenically differentiated MSCs (OST-MSCs) 
for HSCs. We showed that MSCs, ADI-MSCs and OST-MSCs were able to support 
the proliferation of HSCs and maintain their primitive immunephenotype. Compared 
to undifferentiated MSCs and OST-MSCs, the co-culture with ADI-MSCs increased 
the proliferation of HSCs much stronger while still maintaining the HSCs at a high 
expression level of CD34.  
 As the impact of the MSCs on HSCs might be caused by epigenetic changes, the 
aging-associated alterations in the marrow niche were studied at the chromatin level. 
To this end, changes in chromatin accessibility were studied in MSCs by ATAC-seq. 
After establishing the protocol for performing ATAC-seq using primary MSCs, we 
studied the MSC samples derived from 16 healthy human subjects of different ages 
between 21 and 59 years. A set of 122,884 ATAC-seq peaks was identified. We have 
demonstrated that donor age is associated with alterations in open chromatin profiles. 
Moreover, at a false discovery rate of 5%, we could identify 4,579 differential 
chromatin accessible sites upon aging. A functional analysis of these sites showed 
enrichment of cell development and differentiation processes. Additionally, genes of 
the hippo signaling pathway, TGF-beta signaling pathway, cancer pathways and cell 
adhesion pathways were also found to be enriched. A motif enrichment analysis 
suggested that TATA box motifs and binding sites for transcription factors TFAP2C, 
KLF16, HIC1.p2, WT1 and MTF.p2 were enriched in promoter regions of differential 
chromatin accessible sites upon aging. 
In conclusion, this study showed that the interplay with the stem cell niche controls 
HSC functions. The differentiation of MSCs affects the proliferation and stemness of 
HSCs in vitro. Furthermore, we have demonstrated that aging is associated with 
chromatin accessibility alterations in MSCs, which provides a foundation for further 
in-depth mechanistic analyses. 
 
 
 
 
 
 
 
 
 
 Zusammenfassung 
 
Der Alterungsprozess ist ein komplexer Vorgang, der mit Änderungen in vielen 
Körperteilen im Laufe des menschlichen Lebens assoziiert ist. In der folgenden Arbeit 
wurden verschiedene Aspekte des Alterungsvorgangs im menschlichen 
Knochenmark untersucht. 
Da die regenerative Kraft eines Gewebes verbunden ist mit dem Potential seiner 
Stammzellen, die angehäuften Schäden zu ersetzen, wurde der Alterungsprozess 
somatischer Stammzellen untersucht mit dem Fokus auf den Einfluss der Nische, die 
Stammzellalterung zu steuern. Aufgrund der Zugänglichkeit in gesunden Menschen 
wurden die hämatopoetischen Stammzellen zusammen mit anderen Bestandteilen 
der Knochenmarknische als ein allgemeines Modell für den Alterungsprozess 
somatischer Stammzellen untersucht. Die Probenspender waren im Alter von 20 bis 
60 Jahren mit einem medianen Alter von 33.2 Jahren. 
Für jede Knochenmarkprobe wurden die CD34+ hämatopoetischen Stammzellen 
(HSC) und vier andere Zellpopulationen, Lymphozyten und Vorläufer (LYM), 
Monozyten/Makrophagen und Vorläufer (MON), Granulozytische (GRA) und 
erythroide Vorläufer (ERP) mittels Durchflusszytometrie isoliert. Die mesenchymalen 
Stromazellen (MSC) wurden durch in vitro Kultur isoliert. Wir fanden heraus, dass die 
relativen Anteile, Zellgröße sowie Zellgranularität der Knochenmarkbestandteile nicht 
mit dem biologischen Alter der Spender korrelierten. Weitere nachfolgende Analysen 
zeigten jedoch, dass die altersassoziierten Änderungen auf Proteinebene prominent 
waren, sowohl in HSCs als auch in anderen Zelltypen der Nische, wie zum Beispiel in 
MSCs. 
Die Wechselwirkungen zwischen den hämatopoetischen Stammzellen und der 
Nische wurden in vitro untersucht mittels eines Kokultur-Systems bestehend aus 
CD34+ hämatopoetischen Stammzellen und mesenchymalen Stromazellen. Da 
frühere Studien zeigten, dass sich sowohl die supportive Funktion als auch das 
adipogene und osteogene Differenzierungspotential der MSCs signifikant mit dem 
Alter ändern, wurden die supportiven Fähigkeiten der unbehandelten MSCs im 
Gegensatz zu adipogen-differenzierten MSCs (ADI-MSC) und osteogen-
differenzierten MSCs (OST-MSC) untersucht. Wir konnten zeigen, dass MSCs, ADI-
 MSCs und OST-MSCs sowohl die Proliferierung als auch den Erhalt des primitiven 
Immunphänotyps der HSCs unterstützten. Verglichen mit unbehandelten MSCs und 
OST-MSCs, hob die Kokultur mit ADI-MSCs die Proliferierung der HSCs viel stärker 
an während die Expression des CD34 Antigens gleichzeitig hoch blieb. 
Da die Auswirkung der MSCs auf HSCs von den epigenetischen Änderungen erzeugt 
werden könnte, wurden die altersassoziierten Änderungen in der 
Knochenmarknische auf Chromatinebene untersucht. Die Änderungen der offenen 
Chromatin-Zugänglichkeit in MSCs wurden mittels ATAC-Sequenzierung (ATAC-seq) 
erforscht. Nach der Anpassung des Protokolls wurden MSC proben aus 16 gesunden 
Menschen unterschiedlichen Alters zwischen 21 und 59 Jahren analysiert. Aus dem 
erzeugten Datensatz wurde eine Reihe von 122.884 ATAC-seq Peaks identifiziert. 
Wir zeigten, dass das Spenderalter assoziiert war mit den Änderungen in den 
offenen ATAC-seq Chromatinprofilen. Außerdem konnten wir 4.579 
altersdifferenzielle ATAC-seq Peaks mit einer False Discovery Rate von 5% 
identifizieren. Eine funktionale Anreicherungsanalyse der altersdifferentiellen ATAC-
seq Peaks zeigte, dass Zellentwicklung und Differenzierungsprozesse angereichert 
waren. Zusätzlich waren die Gene der Hippo und TGF-beta Signalwege sowie Krebs- 
und Zelladhäsionssignalwege angereichert. Eine Motivanreicherungsanalyse deutete 
darauf hin, dass die TATA-box Motive und Bindungsstellen für Transkriptionsfaktoren 
TFAP2C, KLF16, HIC1.p2, WT1 sowie MTF.p2 in Promotorregionen der 
altersdifferentiellen Peaks angereichert waren. 
Zusammenfassend zeigte diese Studie, dass das Zusammenspiel mit der 
Stammzellnische die HSC Funktionen steuert. Die Differenzierung der MSCs 
beeinflusst die Proliferierung und Stammzellfähigkeit der HSCs in vitro. Des weiteren 
zeigten wir, dass der Alterungsprozess assoziiert ist mit Änderungen der Chromatin-
Zugänglichkeit in MSCs, was eine Grundlage für weitere mechanistische Analysen 
darstellt.  
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1. Introduction  
1.1 Outline of the thesis 
 
Bone marrow is the site of blood formation in postpartum human life. The 
hematopoietic stem cells (HSCs) residing in the bone marrow are supported and 
regulated by the surrounding microenvironment of the bone marrow. As the 
regeneration of the blood system is linked to the potential of HSCs to replace the 
corresponding damaged cells and tissues, one could argue that the blood system is 
as old as its stem cells (Ho et al., 2005).  
In this thesis, my goal is to investigate the molecular signatures of aging in the 
hematopoietic stem cell niche:  
(1) Characterize relative quantitative and morphologic changes upon aging in the 
major constituents of the human bone marrow using flow cytometry. 
(2) Study interactions between hematopoietic stem cells and aged stem cell niche 
using an in vitro niche model.  
(3) Define the chromatin accessibility landscape underlying aging stem cell niche 
using ATAC-seq.  
This work was performed in the research groups of Prof. Anthony D. Ho and Dr. 
Anne-Claude Gavin. The ATAC-seq project was performed in collaboration with the 
research group of Dr. Judith Zaugg.  
 
The “Introduction” chapter describes the background of the thesis, where biological 
concepts relevant for this study are first introduced. As an integral part of the thesis, 
chromatin accessibility and its recent profiling methods are also discussed in the 
context of aging.  
In the chapter “Materials and Methods”, all experiments performed in this study are 
depicted, including optimizations or adaptions, which differ from the standard 
protocols. 
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In chapter “Results”, I first illustrate the alterations in the major constituents of the 
bone marrow with age from flow cytometry data. I then demonstrate interactions 
between HSCs and the niche in vitro using a co-culture system of HSCs and 
undifferentiated MSCs, adipogenically differentiated MSCs and osteogenically 
differentiated MSCs. Lastly, I studied the changes in the epigenetic landscape of the 
aging MSCs using ATAC-seq. Genome-wide profiles and findings for variations in 
chromatin accessibility are presented and discussed.  
In “Discussion and Outlook”, the significance of our results in relationship to those of 
other authors in the literature is deliberated. The relevant conclusions that we can 
derive from our results are discussed. Potentials for further analysis and future 
research work are proposed with the aim to obtain a more holistic understanding of 
the aging process both in HSCs as well as in the bone marrow niche.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1. Introduction 
 
15 
 
1.2 The human bone marrow and hematopoiesis 
 
In adult humans, bone marrow is the site of blood formation (hematopoiesis). The 
bone marrow can be divided into red and yellow marrow (Bain et al., 2009). The red 
marrow contains predominantly hematopoietic cells whereas the yellow marrow is 
largely adipose tissue. The ratio between hematopoietic cells to fat has been used to 
estimate bone marrow cellularity. This ratio decreases with age. In newborns, 
virtually the entire bone cavity is filled by red marrow. With age, the ratio between red 
and fatty marrow is gradually shifted in favor of the latter. Despite this general 
observation, there is considerable individual variability in the distribution of red and 
yellow marrow (Hashimoto, 1962). According to the demand for production of blood 
cells, the red marrow can expand. In addition to the hematopoietic cells, the bone 
marrow also consists of many stromal and supportive elements such as 
mesenchymal cells, fibroblasts, osteocytes and adipocytes. Together with the 
hematopoietic stem and progenitor cells, these cellular subpopulations constitute the 
so-called hematopoietic stem cell compartment which is responsible for the 
maintenance and regulation of hematopoiesis.  
 
1.3 Hematopoietic stem cell compartment 
 
The hematopoietic compartment consists of hematopoietic stem cells (HSC) and their 
progenitors, as well as cells of the bone marrow microenvironment referred to as the 
niche. The interactions between stem cells and the niche are important for the 
maintenance of biological functions in the bone marrow.  
 
1.3.1 Hematopoietic stem and progenitor cells 
 
Hematopoietic stem cells (HSC) are multipotent, thus they can maintain their cell 
number by proliferation as well as differentiate into all functional cell types of the 
blood (Seita et al., 2010). This unique characteristic of stem cells, i.e. both self-
1. Introduction 
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renewal and differentiation is achieved by a precise regulation of asymmetric versus 
symmetric divisions of the cells (Ho et al., 2007; Seita et al., 2010). The division into 
two daughter cells both with stem cell characteristics is called symmetrical division 
whereas the asymmetrical division results in one daughter cell with stem cell 
characteristics and the other one destined to give rise to more mature progenitors 
with subsequently more limited self-renewal capacity (Ho et al., 2007; Seita et al., 
2010). After a number of divisions, mature and functional erythrocytes, monocytes 
and granulocytes, and megakaryocytes are derived from the common myeloid 
progenitors. The lymphoid lineage differentiation leads to the formation of T- , B-
lymphocytes and natural killer cells (Seita et al., 2010) (Figure 1).  
The existence of HSCs in the bone marrow was first proven by Till and McCulloch in 
the early 1960s. In a mouse transplantation assay, they could observe that some 
bone marrow cells injected into irradiated mice could form proliferating colonies in the 
spleen (Till et al., 1961). Some of these cells were able to build up the entire blood 
system when they were injected into secondary hosts in serial transplantation models 
(Siminovitch et al., 1963).  
The isolation and characterization of HSCs are commonly based on the cluster of 
differentiation (CD) antigens expressed on the cell surface. The surface antigen 
CD34 is currently the most important marker to characterize human HSCs (Civin et 
al., 1984; Katz et al., 1985). CD34 represents a surrogate marker for a population 
that is enriched for hematopoietic stem and progenitor cells with a significant 
percentage of HSCs (Giebel et al., 2008). The CD34+ cell population is, for the 
purpose of this study, defined as HSC (Figure 1).  
Due to the fact that CD34 enriched cell population is heterogeneous, additional 
markers such as CD38 are frequently used to identify more primitive stem cell 
populations (Sutherland et al., 1989; Weilbaecher et al., 1991; Petzer et al., 1996). In 
addition to the expression of cell surface markers, HSCs can also be characterized 
based on their division kinetics. Wagner et al. and Huang et al. examined the 
immunephenotypes of slow and fast dividing HSCs which were both derived from the 
CD34+/CD38- population and could show that HSC stemness was associated with 
the slow dividing cell population (Huang et al., 1999; Wagner et al., 2004). 
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Figure 1 A simplified overview of human hematopoiesis. Hematopoietic stem and progenitor cells 
give rise to both the myeloid and lymphoid lineages of blood cells. HSC, hematopoietic stem cell; MPP, 
multipotent progenitor; CMP, common myeloid progenitor; CLP, common lymphoid progenitor; MEP, 
megakaryocyte and erythroid progenitor; GMP, granulocyte−macrophage progenitor; Pro-B, pro-B cell; 
Pro-T, pro-T cell; ERP, erythroid precursors; MON, monocytes, macrophages and restricted 
precursors; GRA, granulocytic precursors; LYM, lymphocytes and restricted precursors. Cell types 
isolated and studied in the course of the project are marked by dashed boxes. Figure was adapted 
from Larsson et al. (Larsson et al., 2005).  
 
1.3.2 The hematopoietic stem cell niche 
 
The bone marrow niche provides a specialized microenvironment for the regulation of 
HSCs (Nakamura-Ishizu et al., 2014). The interactions between the stem cells and 
the niche are mainly based on three mechanisms: signaling through cytokines, direct 
cell-cell interactions and contacts to the extracellular niche matrix (Moore, 2006).  
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The concept of stem cell niche was first proposed by Schofield as physiologically 
constrained microenvironment in which the stem cells reside (Schofield, 1978). In the 
bone marrow, precursor cells of both lymphoid and myeloid lineages as well as 
stromal cells play important roles in the regulation of HSC fate (Wilson et al., 2006). 
In the present study, the entire population of the bone marrow mononuclear cells 
(cells with single nucleus) was isolated as constituents of the HSC niche. This 
includes lymphocytes and restricted precursors (LYM), monocytes, macrophages and 
restricted precursors (MON), granulocytic precursors (GRA) and erythroid precursors 
(ERP). In addition to the hematopoietic cells, one major component of the bone 
marrow supportive stroma mesenchymal stromal cells (MSCs) were isolated and 
expanded by in vitro culture.  
Results derived from animal models showed that in vivo, the hematopoietic 
compartment can be functionally separated into two types – the endosteal (also 
called as osteoblastic) niche and the perivascular niche (Nakamura-Ishizu et al., 
2013). The endosteal niche is located close to the endosteum of the bone with low 
oxygen and nutrient supply. The major constituents of the niche are osteoblasts and 
mesenchymal stromal cells, which are osteoblast precursors (Nakamura-Ishizu et al., 
2013). The osteoblasts secrete a number of cytokines including M-SCF, RANKL, Il7 
and c-FMS regulating the lymphoid and osteoclast development. A subpopulation of 
the osteoblasts expressing cell adhesion protein N-cadherin (spindle-shaped N-
Cadherin+ CD45- osteoblastic cells, SNO) maintains the quiescent state of HSCs by 
cell-cell contacts (Zhang et al., 2003). The vascular niche is located close to the 
blood vessels. It mainly consists of endothelial cells of sinusoidal vessels, which 
support the proliferation and differentiation of HSCs (Kopp et al., 2005). HSCs in the 
vascular niche are subjected to high oxygen and nutrient concentrations. Due to its 
close proximity to the vascular system, the vascular niche probably also supports the 
trans-endothelial migration of HSCs from the bone marrow into the perivascular blood 
system (Lapidot et al., 2005).  
 
 
 
 
1. Introduction 
 
19 
 
1.3.3 HSC homing and mobilization  
 
Albeit the HSCs principally reside in the bone marrow, they might migrate from the 
bone marrow niche to the peripheral blood system. The natural release of HSCs into 
the peripheral blood can occur as response to blood loss, inflammation or injury 
induced by chemotherapy or irradiation (Lapidot et al., 2005). Vice versa, the 
migration of HSCs from the circulation back to the bone marrow niche is called 
homing. The processes of homing and mobilization are regulated by mechanisms of 
reversible cell-cell contacts and trans-endothelial migration (Lapidot et al., 2005). The 
most well-studied mechanism in the processes of HSC homing and mobilization is 
the interaction between the cytokine SDF-1 (stromal cell-derived factor 1) with its 
receptor CXCR4. The osteoblasts and stromal cells of the bone marrow niche 
secrete SDF-1 into the blood system. This signal is sensed by HSCs through the 
CXCR4 receptors on the cell surface. Along the increasing concentration gradient of 
SDF-1, the HSCs are able to migrate back into the bone marrow (Lapidot et al., 
2005). The trans-endothelial migration of the HSCs through the blood-marrow barrier 
is enabled by a group of adhesion proteins such as selectin E and P, integrin alpha 4 
and 5, lFA1 (lymphocyte function-associated antigen-1), CD44 and the Rho GTPase 
Rac 1 and 2 (Kopp et al., 2005; Lapidot et al., 2005).  
The HSCs can be mobilized into the peripheral blood by stress such as at the time of 
recovery after chemotherapy. The mobilization could be induced by the compound G-
CSF (granulocyte-colony stimulating factor) which activates the cleavage of SDF-1 by 
proteases such as elastase, cathepsin G, MMP-2 and MMP9 (Jansen et al., 2005). 
The CXCR4 antagonist AMD3100 is also capable of inducing migration of the HSCs 
in the bone marrow (De Clercq, 2003). The understanding of the mobilization and 
homing processes has led to advancements in clinical stem cell transplantation 
techniques. HSCs used for transplantation treatments against leukemia were initially 
isolated from the bone marrow. Since 1985, the sampling of HSCs for clinical stem 
cell transplantations has been primarily isolated from mobilized peripheral blood due 
to better treatment effects resulting in better reconstitution of the bone marrow (Ho et 
al., 2000). Within a decade, mobilized peripheral blood has replaced bone marrow for 
the vast majority of autologous transplant procedures (Ho et al., 2000).  
 
1. Introduction 
 
20 
 
1.3.4 Aging of the human hematopoietic stem cell compartment 
 
The regenerative potential of a tissue decreases upon aging. For the blood system, 
the regeneration depends on the hematopoietic stem cell compartment in the bone 
marrow (Ho et al., 2005; Wagner et al., 2009). Aging is a gradual and cumulative 
process which varies between individuals, the most commonly observed phenotypes 
associated with physiological aging focus on the primitive hematopoietic stem cell 
(HSC) population (Geiger et al., 2013) (Figure 2).  
It was observed based on studies mostly in mouse models and a few in humans that 
the number of HSCs identified with cell surface markers increased by two- to ten-fold 
in aged human bone marrows (Rossi et al., 2005; Chambers and Goodell, 2007; 
Beerman et al., 2017). Some of the authors suggested that the increase in HSC 
number might counteract the functional decline of an aged blood system by a higher 
level of blood cell regeneration. Experimental data could not, however, support this 
hypothesis. Mouse transplantation assays demonstrated that aged HSCs exhibited a 
diminished regenerative potential (Sudo et al., 2000). Despite the increased cell 
number, the regenerative capacity of the entire HSC pool was reduced in aged 
individuals. The presence of CD34+ HSCs in high numbers might be due to an 
increased frequency of symmetric cell divisions leading to impaired regeneration 
potential of the daughter cells (Sudo et al., 2000). Moreover, the aged HSCs 
exhibited diminished responsiveness to cytokines secreted when transplanting aged 
HSCs into young recipients in the mouse model suggesting that HSC-intrinsic 
mechanisms are more responsible for this aging phenotype (Rossi et al., 2005).  
The second commonly observed phenotype is skewed differentiation potential of 
aged HSCs towards myeloid lineage. Aged HSCs tend to differentiate more into cells 
of myeloid lineage whereas the output of lymphoid-lineage cells is decreased 
(Beerman et al., 2017). Comparing to young HSCs, the absolute number of myeloid 
cells formed by aged HSCs is increased (Beerman et al., 2017). However, despite 
the increased cell quantity, the biological function of the produced myeloid cells is 
reduced (Signer et al., 2007). The lymphoid to myeloid lineage skewing might be 
caused by changes in HSC differentiation or by altered proliferation of myeloid and 
lymphoid precursors. Other authors applied the single-cell technique to study the 
functional heterogeneity in the primitive HSC population. They showed that the 
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differentiation potential of cells in the primitive HSC population varied strongly from 
each other (Muller-Sieburg et al., 2006; Benz et al., 2012). Some HSC subtypes 
tended to differentiate into myeloid cells and were thus myeloid-biased, some cells 
were balanced whereas some other cells were lymphoid-biased. The observed 
lineage skewing might also be caused by the different composition of the HSC 
subtypes upon aging (Muller-Sieburg et al., 2006). In conclusion, the lineage skewing 
phenotype might be caused both by changes in the HSC pool composition as well as 
by alterations in the differentiation potential at a cellular level in the individual HSCs 
(Challen et al., 2010; Dykstra et al., 2011).  
The third phenotype associated with aging HSCs is the diminished homing and 
mobilization property (Köhler et al., 2009). It was shown that young and aged HSCs 
have distinct selectivity for the bone marrow niche in vivo. Aged HSCs tend to home 
to a bone marrow niche at a position more distant to the endosteum bone (Köhler et 
al., 2009). In vitro studies showed that aged HSCs exhibit increased mobilization 
compared to young cells (Florian et al., 2012).     
Consistent with the lineage skewing previously described, Rossi el al. observed in 
aged HSCs a down-regulation of lymphoid-specific genes and up-regulation of 
myeloid-specific genes such as RUNX1, which could possibly explain the lineage 
skewing phenotype (Rossi et al., 2005). Beside common mechanisms of aging such 
as oxidative damage by reactive oxygen species (ROS) (Ito et al., 2004), DNA 
damage accumulation and telomere shortening (Rossi et al., 2008), the epigenetic 
mechanisms also play an important role for aging HSCs (Chambers et al., 2007).  
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Figure 2 Commonly known aging phenotypes and intrinsic mechanisms in human HSCs. In 
aged HSCs, an increased differentiation potential towards cells of myeloid lineage and a decreased 
potential towards cells of lymphoid lineage were commonly observed. Moreover, the rate of 
proliferation and mobilization from the niche increased upon aging. On transcriptome level, the 
expression of genes associated to myeloid differentiation (HOXA9, AURKA, FOS, MYC) increased 
while decreased expression was observed for genes associated to lymphoid differentiation (FLT3, 
SOX4). The expression of cell adhesion genes ICAM1 and SELP increased in aged HSCs. The genes 
of the NF-κB inflammatory signaling pathway (TLR4, COX2, NF-κB) were also up-regulated upon 
aging. On epigenetic level, the genes associated to myeloid differentiation were hypomethylated 
whereas genes associated to lymphoid differentiation were hypermethylated. Furthermore, the 
nucleosome remodeling complexes SWI/SNF and histone deacetylases were down-regulated upon 
aging. CLP, common lymphoid progenitors; CMP, common myeloid progenitors.  
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Isabelle Hellwig, a former colleague from the research group of Dr. Anthony D. Ho 
studied methylation changes in CD34+ HSCs from donors of different ages. She 
found 192 CpG dinucleotides with significantly increased methylation whereas a loss 
of methylation was measured at 350 CpG sites upon aging. The aging-related 
hypomethylation showed high analogy with the hypomethylation of myeloid 
differentiation-associated genes, suggesting that DNA-methylation changes 
contribute to the myeloid lineage skewing observed in aged HSCs (Bocker et al., 
2011; Winnefeld et al., 2012). Beyond that study, changes in DNA methylation 
patterns upon aging were also reported by other groups (Bocker et al., 2011; Hogart 
et al., 2012; Beerman et al., 2013). 
Modifiers of the chromatin structure were also shown to change upon aging. 
Chambers and colleagues observed a general down regulation of genes related to 
chromatin remodeling SWI/SNF complex and histone deacetylases HDAC1, HDAC2 
and HDAC6 (Chambers et al., 2007). Moreover, it was observed in aged HSCs that 
multiple members of the polycomb repressive complexes PRC1 and PRC2 are 
differentially regulated (Klauke et al., 2011). The reason for the altered epigenetic 
status might be due to failures of DNA methyl transferases (DNMTs), histone 
methyltransfereases and acetyltransferases to pass on the HSC-specific epigenetic 
information to the newly synthesized DNA strands of the daughter HSCs upon cell 
proliferation (Rando et al., 2012).  
Niche-derived factors also contribute to the aging phenotypes of HSCs. As previously 
described, SDF1 is an important protein factor for HSC homing produced by 
osteoblasts and MSCs in the bone marrow niche. As the fat content increases with 
age, the blood plasma level of SDF1 decreases, resulting in altered homing and 
mobilization behavior in aged HSCs. The enhanced adipogenesis might be due to 
the lineage skewing of MSCs towards adipogenic differentiation upon aging 
(Tuljapurkar et al., 2011; Kubo et al., 2012). 
In conclusion, an aging stem cell niche in the bone marrow affects the physiology of 
HSCs in many different aspects (Figure 2). One of the most important cell types of 
the niche is the mesenchymal stromal cell.  
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1.4 Mesenchymal stromal cells 
 
Mesenchymal stromal cells (MSCs) are cells of mesenchymal origin which are found 
in the bone marrow, adipose and muscle tissues, brain and vascular vessels 
(Dominici et al., 2006). This cell type was initially discovered and characterized by 
Friedenstein and colleagues early 1970s (Friedenstein et al., 1976). The 
mesenchymal stromal cells are alternatively called “mesenchymal stem cells” due to 
their ability to differentiate into osteocytes (bone cells), adipocytes (fat cells) and 
chondrocytes (cartilage cells) (Pittenger, 1999) (Figure 3). The MSCs are commonly 
characterized by their plastic adherent growth, immunophenotype and in vitro 
differentiation potential (Horwitz et al., 2005). Thus far, there is no specific cell 
surface marker that could be used to specifically identify MSCs. To characterize 
MSCs, a combination of several markers was suggested such as CD90, CD73 and 
CD105. In addition, markers such as CD45 and CD34 are required to be absent 
(Dominici et al., 2006).   
 
The multipotency of MSCs can be confirmed in vitro by 21 days of differentiation. 
There are significant microscopic changes in the cell morphology during the 
differentiation process. Adipogenically differentiated MSCs contain vacuoles filled 
with triglycerides, osteogenically differentiated cells are characterized by calcium 
phosphate and inorganic hydroxyapatite precipitates whereas chondrogenically 
differentiated cells show strong secretion of extracellular mucopolysaccharides 
(Figure 3). The adipogenic and osteogenic differentiation of MSCs could be 
demonstrated reproducibly in vitro by exposing the MSCs to the respective media 
containing differentiation agents. During the adipogenic differentiation, a set of genes 
are highly expressed such as peroxisome proliferator-activated receptor gamma 2 
(PPARγ 2), CCAAT/enhancer binding protein alpha (C/EBPα) and fatty acid binding 
protein 4 (FABP4). During the osteogenic differentiation, osteopontin, osteocalcin 
and runt-related transcription factor 2 (RUNX2) are strongly expressed (Siersbaek et 
al., 2010; Polini et al., 2011; Rippo et al., 2013).  
 
Due to strong population heterogeneity and the lack of a unique immunephenotype, 
the usage of a standardized protocol for isolating MSCs is crucial for the 
experimental design. In vitro studies indicated that isolation and culture conditions 
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have a strong influence on the molecular phenotypes of MSCs. It might lead to 
misinterpretations of experimental results if they are not kept constant for all samples 
within one experiment (Wagner et al., 2007). Especially the composition and 
concentration of the culture medium affect strongly the differentiation potential of 
MSCs (Wagner et al., 2007).  
 
All MSC samples used in the present study were derived from the bone marrow of 
healthy human individuals. The same type of maintenance medium (7th medium) was 
used for isolation, maintenance and expansion of the cells (details described in 
Methods and Materials).   
 
 
 
 
Figure 3 Bone marrow derived mesenchymal stromal cells (MSC) possess the ability to self-
renew as well as to differentiate. The MSCs located in proximity to the bone can be differentiated 
into osteoblasts, chondroblasts and adipoblasts which further maturate into osteocytes, chondrocytes 
and adipocytes. The figure was adapted from Verovskaya et al. and Frenette et al. (Frenette et al., 
2013; Verovskaya et al., 2017).   
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1.4.1 Interactions of MSCs with other cell types 
 
MSCs can interact with other cell types through cytokines or cell-cell contacts. For 
example, it was shown that MSCs secrete a set of cytokines such as EGF, VEGF-α, 
IGF-1, KGF, Angiopoietin-1 and SDF-1, which affect the proliferation and migration of 
endothelial cells and hematopoietic cells upon in vitro co-culture (Wagner et al., 
2008). Additionally, MSCs exert a modulatory function on the innate and adaptive 
immune system by modulating the proliferation and migration of T- and B-cells, NK-
cells, dendritic cells, neutrophils and monocytes. These influences can be exerted by 
cell-cell contacts or secreted cytokines such as nitrogen oxide, interleukin, 
prostaglandin E2 and interferon-gamma (Shi et al., 2011; Le Blanc et al., 2012). In 
vivo MSCs are able to increase angiogenesis and improve wound healing by 
recruiting endothelial cells (Sensebé et al., 2010). Furthermore, MSCs interact via 
cell surface receptors such as integrin beta 1 with hematopoietic stem cells (Walenda 
et al., 2010). As feeder cells, MSCs can promote the proliferation as well as the 
maintenance of HSC stemness ex vivo. Based on this property, an in vitro HSC-
MSCs co-culture system was established to study the interactions between the niche 
and hematopoietic stem cells (Docheva et al., 2007; Huang et al., 2007; Méndez-
Ferrer et al., 2010; Walenda et al., 2010). 
 
1.4.2 HSC-MSC in vitro co-culture system  
 
The HSC-MSC in vitro co-culture system serves as a surrogate model to study the 
cross-talks between HSCs and the bone marrow niche. As described above, 
osteoblasts and MSCs are essential constituents of the endosteal niche in vivo. In the 
murine system, it was shown that the majority of the bone marrow stromal cells are 
derived from MSCs (Muguruma et al., 2006; Wang et al., 2006). Moreover, the MSCs 
express typical niche-derived factors such as SDF-1, VCAM-1, SCF, osteopontin and 
angiopoietin-1 (Nilsson et al., 2005). Either through direct cell-cell contact or as 
secreted cytokines, these factors affect the physiology of HSCs. The cytokine SDF-1 
regulates HSC migration to the bone marrow niche (Ponomaryov et al., 2000); 
vascular cell adhesion molecule-1 (VCAM-1) mediates MSC-HSC adhesion 
(Simmons et al., 1992; Papayannopoulou et al., 1995); stem cell factor (SCF) 
maintains HSC quiescence and niche retention (Kent et al., 2008); angiopoietin-1, 
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osteopontin and thrombopoietin-1 contribute to the maintenance of HSC quiescence 
(Arai et al., 2004; Nilsson et al., 2005; Stier et al., 2005; Qian et al., 2007; Yoshihara 
et al., 2007). Based on the flexibility of this model, efforts were made to study the 
effects of an aging bone marrow niche on the phosphorylation of HSC proteome 
(Karimbocus, 2016). Using the method of stable isotope-labeling with amino acids 
(SILAC), the MSCs and HSCs in the co-culture were labeled with heavy and light 
amino acids, respectively (Mann, 2006). Protocols were established to study the early 
phosphorylation events upon MSC and HSC co-culture (Karimbocus, 2016).  
 
1.4.3 Clinical applications of MSCs 
 
Beyond serving as bone marrow niche, there is a wide range of potential clinical 
applications for human MSCs (Sensebé et al., 2010). The therapeutic usages of 
MSCs are widely explored due to their differentiation potential, regeneration 
promoting properties and suppressive influences of the immune system (Sensebé et 
al., 2010). MSCs are used in tissue engineering of bones, cartilages and connective 
tissues due to their potential to differentiate into osteoblasts and cartilage cells. 
Taking advantage of their positive effects on proliferation and differentiation of 
endogenous cardiac stem cells, MSCs are also applied in cardiovascular diseases 
(Sensebé et al., 2010). The immunosuppressive properties of the MSCs have led to 
several studies on the treatment of graft-vs.-host disease (GvHD) or multiple 
sclerosis (Le Blanc et al., 2012). Possible risks for clinical applications in these areas 
are immortalization or the transformation of MSCs in vivo (Frenette et al., 2013). The 
attempt to use MSCs as feeder cells for HSC expansion in a clinical context bears a 
great potential. However, for possible therapeutic applications, it is crucial to 
understand the physiology and proliferation behavior of MSCs, especially with regard 
to aging and replicative senescence.  
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1.4.4 Aging of MSCs 
 
All cells of the human body are subjected to aging. For human bone marrow MSCs, 
one differentiates between the biological aging process in vivo and the replicative 
senescence in vitro (Ho et al., 2005). Phenotypes of in vivo aging are determined by 
the chronological age of the sample donors while replicative senescence is 
characterized by the number of cell divisions in vitro. Several studies indicated that 
the differentiation potential of MSCs seems to change with age (Figure 4). Stenderup 
and colleagues studied the osteogenic differentiation of MSCs and showed that aging 
is associated with decreased proliferative capacity of osteoprogenitor cells, 
suggesting that the decreased osteoblastic cell number leads to age-related 
decrease in bone formation (Stenderup et al., 2003). By studying specific molecular 
markers for osteogenic and adipogenic differentiations, it was demonstrated in 
mouse that the intrinsic differentiation potential of MSCs shifts towards adipogenic 
differentiation with age. The expression of the transcription factor PPAR-gamma 2, 
which negatively regulates osteoblast development and positively regulates marrow 
adipocyte differentiation increases with age. The expressions of osteoblast-specific 
transcription factors such as RUNX2 and DLX5 decrease in aged MSCs. The 
expression of the osteoblast-specific markers such as collagen and osteocalcin 
decreases in aged MSCs as well (Moerman et al., 2004). It was further shown that 
the expressions of different components of the Wnt and TGF-beta/BMP signaling 
pathways are altered upon aging which might cause enhanced adipogenesis (Ross, 
2000; Moerman et al., 2004). Moreover, the supportive function of MSCs for HSCs 
was also reported to decrease upon aging (Sethe et al., 2006) (Figure 4). The 
secretion of the cytokine SDF-1 (stromal cell-derived factor 1) regulating the 
processes of HSC homing to the niche was reported to decrease in aged MSCs 
(Wagner et al., 2009). The secreted SDF-1 is sensed by HSCs through the CXCR4 
receptors on the cell surface. Along the increasing concentration gradient of SDF-1, 
the HSCs are able to migrate back to the bone marrow niche (Lapidot et al., 2005). 
 
The replicative senescence is characterized by morphological changes and 
decreased potential of proliferation and differentiation. This phenomenon was first 
described 40 years ago by Leonard Hayflick thus the limit of cell divisions is called 
the Hayflick-Limit (Hayflick et al., 1961; Hayflick, 1965). In replicative senescent 
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MSCs, the cells become larger and more granular after 20 to 50 population doublings 
depending on culture conditions. Meanwhile, the activity of beta-galactosidase and 
the cell apoptosis rate are significantly increased (Zhou et al., 2008). However, to 
what extend the replicative senescence reflects the aging process in vivo is still an 
area of active research. 
The epigenetic regulations are crucial for aging in MSCs. Wolfgang Wagner, a 
previous colleague in the research group of Dr. Anthony D. Ho, studied DNA 
methylation pattern in MSCs derived from old and young human donors. Using a 
human methylation microarray-based technology, it was shown that methylation 
patterns were maintained throughout aging but highly significant differences were 
observed at specific CpG sites (Bork et al., 2010). In terms of CpG islands – 295 
CpGs were hypermethylated whereas 349 CpGs were hypomethylated upon aging. 
Many of these differences were observed in homeobox genes such as HOXA2, 
HOXA5 and HOXA6 as well as genes involved in cell differentiation such as RUNX2, 
DLX5, MGMT and BMP4 (Bork et al., 2010). The main transcription factors for 
osteoblast differentiation RUNX2 and DLX5 were observed to be hypermethylated 
upon aging, which is in line with the previously observed decreased expressions of 
RUNX2 and DLX5 (Moerman et al., 2004; Bork et al., 2010). Some of the methylation 
changes in aged MSCs were in consistence with MSCs undergone multiple passages 
indicating a possible correlation between biological aging and replicative senescence 
(Bork et al., 2010). However, despite the changes in homeobox genes and genes 
responsible for cell differentiation described above, a holistic understanding of the 
changing regulatory landscape in human MSCs upon aging still requires 
investigations on multiple molecular levels.  
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Figure 4 Commonly known aging phenotypes and intrinsic mechanisms in human MSCs. In 
aged MSCs, an increased differentiation potential towards adipocytes and a decreased potential 
towards osteocytes were observed. A decrease in the supportive potential for hematopoietic stem cells 
(HSCs) was shown in co-culture experiments. On transcriptome level, the expression of transcription 
factors associated to adipogenic differentiation (PPARγ2) increased while decreased expression was 
observed for transcription factors associated to osteogenic differentiation (RUNX2, DLX5). The 
expression level of secreted cytokine SDF-1 regulating HSC migration decreased in aged MSCs. On 
epigenetic level, the genes associated to osteogenic differentiation (RUNX2, DLX5) and homeobox 
genes (HOXA 2, 5 and 6) were hypermethylated in aged MSCs. The homeobox genes (HOXB 1, 3, 4 
and 6) were hypomethylated upon aging in MSCs.    
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1.5 Epigenetic regulation in human cells  
1.5.1 Transcriptional regulatory landscape in human  
 
Gene expression is the process that converts the information embedded in a DNA 
template into an RNA molecule. The regulation of gene expression, both in time and 
space, is fundamental for many biological processes such as homeostasis, 
development and responses to environmental cues. In eukaryotes, the first step of 
gene expression, transcription, is carried out by three types of RNA polymerases. 
RNA polymerases I and III transcribe the genes encoding transfer RNA, ribosomal 
RNA, and various small RNAs. RNA polymerase II transcribes all protein encoding 
genes (Alberts et al., 2015). The mechanisms regulating transcription activity are 
mainly achieved through the signals for the initiation of transcription encoded in the 
DNA template and the exposure of this genetic signal.  
In the nucleus, eukaryotic genetic material is wrapped around complexes of histone 
proteins in the form of chromatin (Alberts et al., 2015). The accessibility of the 
condensed DNA is therefore crucial for gene expression control. The initiation of 
gene expression starts with the relaxation of compact chromatin in regulatory regions. 
The initial modification of chromatin structure is commonly carried out by chromatin 
remodeling complexes, modification of histones and sometimes binding of the so-
called pioneer transcription factors (Kouzarides, 2007).  
The opening of compact chromatin leads to the exposure of transcription factors to 
cis-regulatory modules (CRM), which are genomic regions containing regulatory 
information (Armstrong, 2013). The CRMs can be located in close proximity or at 
large distance to the target gene. The transcriptional factors (TFs) bind to 
transcription factor binding sites (TFBS). They interact via co-factors to recruit and 
stabilize the transcription initiation complex to the promoter, upstream of the 
transcription start site (TSS). The transcription of the target gene is then initiated by 
the transcription initiation complex (Figure 5).  
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Figure 5 Overview of transcriptional regulation in eukaryotes. Condensed chromatin relaxes and 
transcription factors (TFs) bind transcription factor binding sites (TFBS) in both distal and proximal cis-
regulatory modules (CRMs). Bound TFs interact with co-factors to stabilize the transcription initiation 
complex to the promoter region enabling gene expression. Figure was adapted from Wasserman et al. 
(Wasserman et al., 2004).   
 
1.5.2 Importance of chromatin accessibility for gene expression 
 
The chromosome is the compact form of chromatin which consists of DNA and 
histone proteins (Armstrong, 2013). The basic unit of chromatin is the nucleosome. It 
consists of 147 bp of DNA wrapped around a protein octamer composed of four core 
histones (H3, H4, H2A and H2B). The positioning of the nucleosome is crucial for the 
regulation of transcription, as DNA wrapped around histones is less accessible than 
the naked DNA (Kaplan et al., 2011; Li et al., 2011). Previous studies also indicated 
that chromatin accessibility is correlated with the rate of transcriptional initiation at 
promoters suggesting that a low nucleosome occupancy at transcriptional start sites 
(TSS) is associated with transcriptional activation (Lee et al., 2004; Shu et al., 2011).  
 
1. Introduction 
 
33 
 
Several mechanisms could lead to chromatin accessibility changes. Conformational 
changes in chromatin structure lead to unwrapping of the nucleosomal DNA, allowing 
transcription factor binding. Changes in nucleosome occupancy can either occur 
through chromatin remodeling by altering the DNA-histone interaction non-covalently 
or through chromatin modification which mainly introduces covalent modifications on 
histone tails. Chromatin remodeling in human is mainly mediated by ATP-dependent 
SWF/SNF protein complex (Segal et al., 2009).  
Despite many contradictory observations, in most organisms, a general model of 
heterochromatin loss upon aging is proposed (Tsurumi et al., 2012). In this model, a 
relaxation of heterochromatin due to down regulation of heterochromatin-silencing 
proteins may cause cellular dysfunctions with age (Pollina et al., 2011; Tsurumi et al., 
2012). Changes in chromatin accessibility are important for the epigenetic regulation 
of the aging process. One prominent mechanism is the post-translational modification 
of histone tails.  
 
1.5.3 Regulation of gene expression by modifications of histone 
tails 
 
The N-terminus of histone tails are mainly modified by acetylation, methylation, 
phosphorylation and ubiquitylation. These modifications can either facilitate the ATP-
dependent chromatin remodeling by SWF/SNF protein or alter directly the stability of 
contacts between DNA and nucleosomes (Armstrong, 2013). In the field of human 
aging, methylation and acetylation of lysines on histone H3 are the best-studied post-
translational modifications.  
Histone methylation is associated with either active or repressed genome regions 
depending on the residue and level of methylation. The methylation status is 
regulated by histone methyltransferases and demethylases. The monomethylation of 
histone H3 (H3K4me1) is enriched downstream of promoters; dimethylation 
(H3K4me2) is enriched in enhancer and promoter regions; whereas the trimethylation 
(H3K4me3) is enriched in promoter regions and involved in transcriptional activation 
(Heintzman et al., 2007). In human fibroblast cells and murine HSCs, new regions of 
H3K4me3 emerged upon aging (Shah et al., 2013; Sun et al., 2014). H3K27me3 is 
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associated with the repressive state of chromatin (Creyghton et al., 2010). Lysine 27 
is methylated by polycomb repressive complex 2 (PRC2) and recognized by 
polycomb repressive complex 1 (PRC1), which in turn silences the gene expression 
by ubiquitylating histone H2A (Simon et al., 2013). Increased H3K27me3 was shown 
in C. elegans with extended longevity (Ni et al., 2012). In aged human fibroblast cells, 
a decrease in H3K27me3 level was observed (Shah et al., 2013). In Drosophila, a 
decrease in H3K27me3 level was associated with aging (Siebold et al., 2010). Taking 
those observations together, one can conclude that different H3K27me3 regulators 
may influence lifespans through specific loci in specific cell types and organisms 
(Pollina et al., 2011).  
 
1.5.4 Genome-wide sequencing methods to study chromatin 
accessibility 
 
Due to the great importance of chromatin openness to the biological functions of the 
cells, many different methods have been developed to profile chromatin accessibility 
on a genome-wide scale. ATAC-seq is a recently introduced method to map 
chromatin accessibility genome-wide (Figure 6A). It stands for “Assay of 
Transposase Accessible Chromatin with Sequencing” (Buenrostro et al., 2013). The 
method is based on the property of the transposase Tn5 to randomly integrate into 
open chromatin regions (Adey et al., 2010). A hyperactive form of Tn5 is used in 
ATAC-seq to insert sequencing adaptors randomly to the open chromatin regions. 
This process is referred to as tagmentation (Figure 6A). A sequencing library is 
prepared by PCR-amplifying the tagmented DNA fragments. The library is then 
sequenced on the next-generation sequencing platforms from both ends of the DNA 
fragment (paired-end sequencing) (Buenrostro et al., 2013).  
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Figure 6 ATAC-seq is a method to probe chromatin accessibility genome-wide. (A) A 
hyperactive Tn5 transposase inserts sequencing adaptors into the open regions of the genome. The 
tagmented DNA fragments are PCR-amplified and sequenced from both ends. (B) Advantages of 
ATAC-seq (green) compared to FAIRE-seq (light blue) and DNase seq (dark blue) are the small 
amounts of starting material required and short sample preparation time. No. of cells (number of cells) 
(C) Fragment size distribution of ATAC-seq library shows a periodicity of approximately 200 bp 
indicating that many fragments are protected by the nucleosomes. Figures were adapted from 
Buenrostro et al. (Buenrostro et al., 2013).   
 
Sequencing reads can be subsequently used to infer nucleosome positions, 
chromatin regions of increased accessibility, as well as to predict transcription factor 
binding from a standard sample size of 500 – 50,000 cells (Buenrostro et al., 2013). 
Recent publications also showed that this method is compatible with single cell 
microfluidic set-ups as well (Buenrostro et al., 2015) 
Clear advantages of ATAC-seq compared to established sequencing methods such 
as DNase-seq or FAIRE-seq (Formaldehyde-Assisted Isolation of Regulatory 
Elements-Sequencing) for assaying chromatin accessibility genome-wide lie in the 
small amount of cell material needed for library preparation as well the short library 
preparation time (Figure 6B). Working with clinical samples, rare cellular subtypes 
like e.g. CD34+/CD38- human HSCs often cannot be isolated in adequate amounts 
for methods like DNase-seq or FAIRE-seq. Another advantage of the small amount of 
starting material is that important biological heterogeneity in cellular populations is 
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not averaged out in the cell population (Buenrostro et al., 2013). The ATAC-seq 
paired-end reads produce detailed information about nucleosome packing and 
positioning (Buenrostro et al., 2013). The size distribution of the ATAC-seq 
sequencing fragments indicates a periodicity of approximately 200 bp indicating that 
many fragments are protected by the nucleosomes (Figure 6C).  
This method was applied to a variety of biological questions. By overlaying ChIP-seq 
data with ATAC-seq data, dynamics of four chromatin modifications across 16 stages 
of murine hematopoietic differentiation were profiled (Lara-Astiaso et al., 2014). 
Among the 48,415 enhancer regions characterized, 17,035 lineage-specific 
enhancers are involved in the lineage commitment of hematopoietic differentiation 
(Lara-Astiaso et al., 2014). By studying primary CD4+ T cells isolated from healthy 
individuals, Qu and colleagues found gender to be a major contributor to the variation 
in chromatin accessibility profiles (Qu et al., 2015). They also revealed novel 
elements that escape X chromosome inactivation and predicted gender-specific gene 
regulatory networks across autosomes (Qu et al., 2015).  
However, despite the large number of studies on chromatin accessibility dynamics, 
none of the studies were carried out in the field of human bone marrow aging. To 
understand the aging process of human hematopoietic stem cell niche, it is important 
to characterize the open chromatin profiles of the bone marrow-derived MSCs.  
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2. Experimental design 
 
In the course of this PhD project, 59 bone marrow aspirate samples derived from 
healthy individuals between age 20 and 60 were collected and characterized by flow 
cytometry. I studied the age-associated proportional, morphological and 
immunophenotypic changes of the major bone marrow constituents comprising of 
hematopoietic stem cells (HSC), lymphocytes and restricted precursors (LYM), 
monocytes, macrophages and restricted precursors (MON), granulocytic precursors 
(GRA) and erythroid precursors (ERP).  
The interactions between HSCs and the niche were studied in vitro using a co-culture 
system of HSCs and MSCs. As the supportive functions and the differentiation 
potentials towards adipocytes and osteocytes change significantly with age, we 
examined the ability of undifferentiated MSCs, adipogenically differentiated MSCs 
(ADI-MSCs) and osteogenically differentiated MSCs (OST-MSCs) to support HSCs. 
The proliferation and stemness of HSCs derived from cord blood and mobilized 
peripheral blood were investigated after seven days of co-culture with those three 
types of feeder cells.   
Taking an unbiased approach, we investigated the epigenetic changes upon aging 
using ATAC-seq in MSCs. To this end, chromatin accessibility profiles were 
generated from a cohort of 16 healthy individuals between ages 21 and 59. 
Chromatin openness variations depending on age were analyzed and preliminary 
findings were discussed.  
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3. Materials and Methods 
 
3.1 Materials 
3.1.1 Primary human samples 
Hematopoietic stem cells (HSC) were separated from cord blood and bone marrow of 
healthy individuals. Mesenchymal stromal cells (MSC) were expanded in vitro from 
the bone marrow of healthy human subjects. Lymphocytes and restricted precursors 
(LYM), monocytes, macrophages and restricted precursors (MON), granulocytic 
precursors (GRA), and erythroid precursors (ERP) were isolated from bone marrow 
of healthy individuals. Ethic approvals from the local ethics committee were available 
for the samples used in this project.  
3.1.1.1 Cord blood 
Cord blood was provided by Heidelberg University Women’s Hospital, Klink Sankt 
Elisabeth Heidelberg and University Hospital Mannheim. The sample was collected 
directly after the delivery of healthy newborns by the responsible delivery nurses. 
Cord blood was transferred by compression of the umbilical vein towards the cord cut 
into a 50 ml Falcon tube provided with 10 ml PBS containing 10% 
Heparin/Sodium2500 as anti-coagulant. The samples were temporally stored at 4-
8 °C for subsequent procedures.  
3.1.1.2 Bone marrow 
Bone marrow of healthy donors was taken by puncture of the iliac crest. The cortical 
bone was drilled under local anesthesia and the bone marrow was sampled by 
continuous aspiration using 20 ml syringes provided with 10.000 units of heparin. The 
bone marrow was subsequently mixed thoroughly with anticoagulant and immediately 
further processed.   
3.1.1.3 Cell lines 
The GM12878 cell line derived from human lymphoblastoid cells was received as 
courtesy of Eleni Kafkia, Patil group, EMBL.  
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3.1.2 Instruments 
Table 1 A summary of instruments used in the project.  
Name Supplier 
2100 Bioanalyzer Agilent Technologies 
AutoMACS separation columns Miltenyi Biotech  
AutoMACSTM Separator Miltenyi Biotech 
B5050 Laboratory Incubator Heraeus 
BD FACSAria III cell sorter BD 
BD FACScan™ Flow Cytometer BD 
BD LSRFortessa cell analyzer BD 
BD Vantage SE cell sorter BD 
Blue light transilluminator, ECX-F20 VWR 
Centrifuges 5810, 5810R, 5415D, 5424 eppendorf 
Colorview-12 camera Olympus  
Coulter MD II Series Analyzer BD 
Gel chamber Febrikon Feinmechanik 
Gel electrophoresis chamber Mini-Cell GT 
Systems 
Bio-Rad 
Gel electrophoresis chamber Wide Mini-Sub Cell 
GT Systems 
Bio-Rad 
HiSeq 2000 Sequencing System Illumina 
HiSeq 2500 Sequencing System Illumina 
Incubator ‘Hera cell’ 150 Kendro Laboratory Products  
Innova 2000 shaker New Brunswick 
Mr. Frosty Thermo Fisher Scientific 
Multifuge 3S-R Heraeus Instruments GmbH 
Nano Drop ND-1000  PeqLab Biotechnologie 
Nexterion B Microscope Slide Schott 
Olympus IX70 Olympus 
Qubit Fluorometer invitrogen  
Sigma 1-15PK microcentrifuge Sigma Laborzentrifugen  
StepOnePlus Real-Time PCR Systems Applied Biosystems 
Sterile bench HERAsafe Heraeus Instruments GmbH 
TC20 Automated Cell Counter BioRad 
TE-2000 Nikon GmbH 
ThermoCell Mixing Block MB-102  Alpha Laboratories 
Transwell (6.5 mm diameter, 0.4 µm pore size) Corning Holding GmbH 
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3.1.3 Chemicals 
Table 2 A summary of chemicals used in the project.  
Name Supplier 
1 kb DNA Ladder New England Biolabs 
100 bp DNA Ladder New England Biolabs 
100 bp plus DNA Ladder Thermo Scientific 
2-Propanol Merck Millipore 
6x DNA Loading Dye Fermentas  
Accutase Sigma-Aldrich 
Agarose Sigma-Aldrich 
Agarose Ultra-Quality Carl Roth  
BD FACSClean BD 
BD FACSFlow BD 
BD FACSRinse BD 
Bovine serum albumin Stemcell Technologies  
Calcium chloride Sigma-Aldrich 
Carboxyfluorescein diacetate N-succinimidyl ester Sigma-Aldrich 
Chloroform Fluka Chemie 
DAPI Roche 
Digitonin Sigma-Aldrich 
DMSO Sigma-Aldrich 
D-PBS PAA Laboratories  
EDTA AppliChem  
Ethanol Merck Millipore 
Ethidium bromide Carl Roth  
FICOLL Separation Solution Biochrom  
Formaldehyde Solution 37% Merck Millipore 
GelGreen Nucleic Acid Gel Stain 10,000x in water Biotium 
Glycerol Merck Millipore 
Heparin/Sodium2500 Ratiopharm  
HEPES Sigma-Aldrich 
Hoechst 33342 Roche Diagnostics 
IGEPAL CA-630 (NP40) Sigma-Aldrich 
Methanol Merck Millipore 
Nuclease-Free Water B. Braun  
Propidiumiodid BD  
Sodium chloride Sigma-Aldrich 
Sodium dodecyl sulfate, SDS Sigma-Aldrich 
Sodium hydroxide Sigma-Aldrich 
Streptomycin Gibco 
SYBR Green PCR Master Mix Applied Biosystems 
Triton-X-100 Sigma-Aldrich 
TRIzol LS Reagent Life Technologies 
Trypsin-EDTA Gibco 
Trypan Blue 0.4% Thermo Scientific 
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3.1.4 Miscellaneous materials 
Table 3 A summary of miscellaneous materials used in the project.  
Name Supplier 
12-well culture plates Corning 
24-well culture plates Corning 
Agencourt AMPure XP beads / SPRI Beckman Coulter  
Agilent High Sensitivity DNA Kit  Agilent Technologies  
BD Falcon Tubes for Flow Cytometer BD 
Cover slips  Thermo Fisher Scientific 
Cryo-vial, 2 ml Nunc 
DNA LoBind Tube 0.5 ml Eppendorf 
DNA LoBind Tube 1.5 ml Eppendorf 
Falcon 15 ml Polystyrene Conical Centrifuge Tubes Thermo Fisher Scientific 
Falcon 50 ml Polystyrene Conical Centrifuge Tubes Thermo Fisher Scientific 
MinElute Gel Extraction Kit  Qiagen 
Neubauer cell counting chamber Brand, Wertheim 
Nextera DNA Sample Preparation Kit Illumina 
Nextera Index Kit Illumina 
PARTEC CellTrics Filter Sysmex 
QIAQuick Gel Extraction Kit Qiagen 
QIAQuick PCR Purification Kit Qiagen 
Qubit dsDNA HS Assay Kit Thermo Fisher Scientific 
Safe-Lock Tubes 1.5 ml Eppendorf 
Safe-Lock Tubes 2.0 ml Eppendorf 
Scapel Blades Roth 
Stericup® and Steritop™ Vacuum Driven Sterile 
Filters 0.22 µm 
Merck Millipore 
T25 culture flasks  Greiner 
T75 culture flasks  Greiner 
 
 
3.1.5 Oligonucleotides 
Table 4 A summary of oligonucleotides used in the project.  
Name Sequence 5' -> 3' Purpose 
N701 TCGCCTTATAAGGCGA Forward barcode primers for ATAC-seq 
library amplification and sequencing N702 CTAGTACGCGTACTAG 
N703 TTCTGCCTAGGCAGAA 
N704 GCTCAGGATCCTGAGC 
N705 AGGAGTCCGGACTCCT 
N706 CATGCCTATAGGCATG 
N707 GTAGAGAGCTCTCTAC 
N708 CCTCTCTGCAGAGAGG 
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N709 AGCGTAGCGCTACGCT 
N710 CAGCCTCGCGAGGCTG 
N711 TGCCTCTTAAGAGGCA 
N712 TCCTCTACGTAGAGGA 
N501 TAGATCGCGCGATCTA Reverse barcode primers for ATAC-seq 
library amplification and sequencing N502 CTCTCTATATAGAGAG 
N503 TATCCTCTAGAGGATA 
N504 AGAGTAGATCTACTCT 
N505 GTAAGGAGCTCCTTAC 
N506 ACTGCATATATGCAGT 
N507 AAGGAGTATACTCCTT 
N508 CTAAGCCTAGGCTTAG 
N517 GCGTAAGATCTTACGC 
 
 
3.1.6 Culture media  
3.1.6.1 Medium for lymphoblastoid cell line 
Table 5 Composition of culture medium for GM12878 cell line.  
Component Concentration Supplier 
RPMI 1640, GlutaMAX supplement 75% Invitrogen 
FBS 25% Invitrogen 
 
 
3.1.6.2 HSC-medium  
Long-term bone marrow culture medium (LTBMC) was used to culture human HSCs.  
Table 6 Composition of long-term bone marrow culture medium (LTBMC medium). 
Component Concentration Supplier 
IMDM 75% PAA Laboratories  
FCS 12.5% Stemcell Technologies 
Horse Serum 12.5% Stemcell Technologies  
Penicillin/Streptomycin 1% PAA Laboratories  
Hydrocortison 100 0.05% Rotexmedica  
L-Glutamine 1% PAA Laboratories  
Flt-3L 10 ng/ml R&D Systems  
TPO 10 ng/ml R&D Systems  
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3.1.6.3 MSC-media 
3.1.6.3.1 MSC maintenance medium  
 
The maintenance culture medium for MSCs (7th medium) was prepared according to 
Zhao et al. (Zhao et al., 2002). 
 
Table 7 Composition of MSC maintenance medium.  
Component Concentration Supplier 
DMEM Low Glucose 60% PAA Laboratories  
MCDB-201 base medium 38% Sigma-Aldrich 
FCS 2% Stemcell Technologies 
L-Glutamine 200 mM 2 mM PAA Laboratories  
Penicillin 10.000 U/ml + Streptomycin 
10.000 U/ml 
100 U/ml PAA Laboratories  
Insulin 1.0 mg/ml + Transferrin 0.55 mg/ml 
+ Selene 0.5 µg/ml Liquid Media 
Supplement 
1% Sigma-Aldrich 
Linoleic acid 1% Sigma-Aldrich 
L-Ascorbic acid 0.1 mM Sigma-Aldrich 
Dexamethasone 20 nM Sigma-Aldrich 
 
 
3.1.6.3.2 Adipogenic differentiation medium 
 
The adipogenic differentiation medium for MSCs was used to induce adipogenic 
differentiation of MSCs previously maintained in 7th medium.  
 
Table 8 Composition of MSC adipogenic differentiation medium. 
Component  Concentration Supplier 
DMEM High Glucose 90% PAA Laboratories  
FCS 10% Stemcell Technologies 
L-Glutamine 200 mM 2 mM PAA Laboratories  
Penicillin 10.000 U/ml + Streptomycin 
10.000 U/ml 
100 U/ml PAA Laboratories  
Insulin 1.0 mg/ml + Transferrin 0.55 
mg/ml + Selene 0.5 µg/ml Liquid 
Media Supplement 
1% Sigma-Aldrich 
1-methyl-3-isobutylxanthin (IBMX) 
 
0.5 mM Sigma-Aldrich 
Dexamethasone 1 nM Sigma-Aldrich 
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3.1.6.3.3 Osteogenic differentiation medium 
 
The osteogenic differentiation medium for MSCs was used to induce osteogenic 
differentiation of MSCs previously maintained in 7th medium.  
 
Table 9 Composition of MSC osteogenic differentiation medium. 
Component Concentration Supplier 
DMEM Low Glucose 90% PAA Laboratories  
FCS 10% Stemcell Technologies 
L-Glutamine 200 mM 2 mM PAA Laboratories  
Penicillin 10.000 U/ml + Streptomycin 
10.000 U/ml 
100 U/ml PAA Laboratories  
L-Ascorbic acid 0.2 mM Sigma-Aldrich 
beta-Glycerophosphate 10 mM Sigma-Aldrich 
Dexamethasone 100 nM Sigma-Aldrich 
 
 
3.1.6.3.4. R10 medium 
Table 10 Composition of R10 medium. 
Component Concentration Supplier 
RPMI medium 1640 90% PAA Laboratories  
FCS 10% Stemcell Technologies 
L-Glutamine 200 mM 2 mM PAA Laboratories  
Penicillin 10.000 U/ml + Streptomycin 
10.000 U/ml 
100 U/ml PAA Laboratories  
HEPES 20 mM Sigma-Aldrich 
 
3.1.7 Buffers  
Table 11 Composition of all buffers used in the project. 
Name Composition/Source 
MACS 
Buffer 
1 % FCS, 2 mM EDTA in PBS 
TAE 
Buffer 
(50x) 
20 M Tris/glacial acetic acid, 5 mM EDTA in 
H2O 
TE Buffer 10 mM Tris-HCl, 1 mM EDTA in H2O 
 
 
 
 
 
 
3. Materials and Methods 
 
46 
 
3.1.8 Antibodies 
Table 12 List of antibodies used in the project. 
Antibody Conjugate Concentration Supplier 
CD34 Mouse IgG1κ APC 100 µg/ml Becton 
Dickinson 
CD38 Mouse IgG1κ PE 50 µg/ml Becton 
Dickinson 
CD45 Mouse IgG1κ FITC 50 µg/ml Becton 
Dickinson 
CD14 Mouse IgG2b PE 50 µg/ml Becton 
Dickinson 
 
3.2 Methods 
3.2.1 Isolation of bone marrow constituents 
The isolation of bone marrow derived HSC, MON, GRA, ERP and LYM was carried 
out by FICOLL density gradient centrifugation followed by FACS sorting according to 
differential expressions of cell surface antigen markers CD34, CD45, CD14.   
3.2.1.1 Density gradient centrifugation 
The mononuclear cells from cord blood and bone marrow were isolated by FICOLL 
density gradient centrifugation. This method is based on the principle that the density 
of FICOLL (1.077 g/ml) is higher than the mononuclear cells but lower than 
erythrocytes and granulocytes. Using this method, different components of blood and 
bone marrow can be separated and isolated according to their density (Jaatinen et al., 
2007).  
 
Figure 7 Phase separation of human bone marrow after density gradient centrifugation. The 
density of FICOLL is higher than the mononuclear cells but lower than erythrocytes and granulocytes. 
Using this method, different cellular components of the bone marrow can be separated according to 
their density.  
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There are four separated phases after a FICOLL centrifugation from top to the bottom: 
the blood serum and platelets phase, the mononuclear cell phase, the FICOLL paque 
phase and the bottom phase consisting of erythrocytes and granulocytes. Up to 30 ml 
cord blood or bone marrow diluted with PBS (ratio 1:1) was transferred into a 50 ml 
Falcon tube provided with 14 ml FICOLL separation solution. The two-phase 
suspension was centrifuged at 12,000 x g and room temperature for 25 min without 
brake. The interphase containing mononuclear cells was subsequently transferred by 
a 15 ml plastic pipette into a new tube containing 50 ml PBS. From this suspension, 
20 µl were used for automatic determination of cell amount by Coulter MD II Series 
Analyzer (Beckman Coulter GmbH, Krefeld). The remaining suspension was washed 
again with 30 ml PBS at 400 g for 7 min.  
 
3.2.1.2 Immunomagnetic isolation of cord blood HSCs 
Cord bloods HSCs were isolated from the mononuclear cell fraction by 
immunomagnetic separation using CD34 MicroBeads (Miltenyi BiotecGmbH, 
Bergisch Gladbach). This method is based on the principle that CD34 antigen 
expressing cells are bound to the CD34 antibody coated on the surface of the 
magnetic MACS Microbeads  allowing a column separation (Miltenyi et al., 1990). As 
a first step, the mononuclear cell suspension was run through a separation column in 
a magnetic field. The magnetic Microbeads with CD34+ cells on the surface were 
trapped in the column while the unbound CD34- fraction was discarded as flow 
through. As a second step, the CD34+ cells were washed out from the column in the 
absence of the magnetic field. For each 108  mononuclear cells suspended in 300 µl  
MACS buffer, 100 µl of FcR blocking reagent was added and mixed with 100 µl 
magnetic CD34 Microbeads. The suspension was incubated for 30 min at 4 °C, 
diluted by MACS buffer to 30 ml and centrifuged at 400 g for 10 min. The cell pellet 
was resuspended in MACS buffer at a ratio of 108 cells per 500 µl MACS buffer. 
Using the AutoMACS system the LS separation column was rinsed once with 3 ml 
MACS buffer. Subsequently the cell-bead suspension was loaded on the column and 
washed three times with MACS buffer. To elute the CD34+ cells out of the column 5 
ml MACS buffer was used in absence of the magnetic field. The isolated cells were 
loaded on the separation column again to increase the purity of CD34+ fraction. The 
isolated CD34+ cells were counted by Neubauer chamber.   
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3.2.1.3 Flow cytometric isolation of bone marrow cells 
The fluorescence-activated cell sorting (FACS) is a method to sort and analyze a 
heterogeneous population of cells based on scattered light and fluorescent properties 
of each single cell. It enables the measurement of the relative cell size, granularity 
and multiple fluorescent dyes simultaneously for more than thousands of cells within 
seconds (Bonner, 1972). Cell probes stained with fluorescent dyes pass through a 
monochromatic laser beam lined-up single-file based on the principle of 
hydrodynamic focusing (Shuler et al., 1972). At the measurement point, scattered 
light and fluorescent signals of the single-cell were registered by optical sensors and 
converted into electronic signals. The scattered light signal of the cell striking the 
photo-detector placed directly in front of the laser beam (at 0° angle) is called 
“forward scatter” which is often taken as a measure for the relative size of a cell 
(Givan, 2004). The scattered light signal of the cell striking the photo-detector placed 
in 90° position to the laser beam is called “side scatter” which is often a measure for 
the irregularities or granularity on the surface or in the cytoplasm of the cell (Givan, 
2004) (Figure 8). The detected fluorescent signals are quantitative measures for the 
relative expression levels of cell surface antigens given the fact that the emitted 
fluorescent signal is proportional to the amount of antibody bound to the cell surface.  
At the analysis point of a flow cytometer with the laser beam, the sheath stream and  
the  lenses  for  collection  of  forward  scatter, side  scatter and fluorescent signals 
are  all  at  orthogonal angles to each other. 
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Figure 8 Principle of fluorescence-activated cell sorting. Bone marrow mononuclear cells were 
sorted into different populations based on forward scatter, side scatter and fluorescence carried by 
conjugated antibodies. At the analysis point, the laser beam, detectors of forward and reverse scatter 
are all at orthogonal angles to the flow direction of the cells. ERP, erythroid precursors; MON, 
monocytes, macrophages and restricted precursors; GRA, granulocytic precursors; LYM, lymphocytes 
and restricted precursors; SSC-A, side scatter area. Picture created based on Givan (Givan, 2011). 
 
 
The FACS sorting was carried out using a BD FACS-Aria III cell sorter with BD 
FACS-Diva operation interface. The data analysis was performed using BD FACS-
Diva software and FlowJo 7.6 Flow Cytometry software. The mononuclear cells were 
resuspended in 1 ml PBS for cell sorting. Four cell aliquots diluted in 100 µl PBS 
were used as autofluorescent and compensation controls. One aliquot was kept 
unstained as autofluorescent control. The other three cell aliquots were stained with 1 
µl CD34 antibody, 1 µl CD45 antibody and 1 µl CD14 antibody, respectively. For 
every 107 mononuclear cells, the suspension was stained with 4 µl CD34, 4 µl CD45 
and 4 µl CD14 antibody at 4 °C for 30 min. The cells were subsequently washed in 
MACS buffer at 400 x g for 6 min. The main sample was resuspended in 1-2 ml 
MACS buffer and filtered through a red PARTEC CellTrics 20 µm filter in a 15 ml tube. 
For cell sorting, 15 FACS tubes provided with 750 µl MACS buffer were prepared. 
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Right before cell sorting, 1 µl propidium iodide was added to each sample to exclude 
apoptotic and necrotic cells. After sorting, a small aliquot of sorted sample was re-
measured on the FACS machine to determine the technical sorting purity. The sorted 
samples were washed once with 50 ml PBS at 400 x g for 7 min and cell pellets were 
frozen in Eppendorf tubes for subsequent procedures.  
 
 
 
 
Figure 9 The mononuclear cell population was separated by hierarchical gating. Mononuclear 
cells were divided into HSCs and non-HSCs by the expression level of CD34 (CD34-APC). The CD34- 
population was further divided into lymphocytes and precursors (LYM), erythroid precursors (ERP), 
and granulocytic precursors (GRA) by their different side scatter properties (granularity) and the 
expression levels of CD45 (CD45-FITC). The monocytes, macrophages and precursors (MON) were 
additionally constrained by the expression level of CD14 (CD14-PE). 
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3.2.2 Isolation of MSCs 
The mononuclear cells isolated from human bone marrow were seeded in 10 ml 7th 
medium in a T75 or T25 culture flask at a density of 1x106 cells per cm2. With an 
optimal cell amount of 2.5x107 cells, the initial medium containing non-adherent cells 
and debris was changed 72 h after seeding. Depending on the adherent growth of 
the MSCs, initial colonies were formed after 10-14 days of culture. MSCs were 
expanded and stored at early passage number (passage <4) in liquid nitrogen. 
Alternatively the MSCs were isolated from filter sets of bone marrow aspiration bags 
used for bone marrow transplantations. Those filter sets contained residual amounts 
of MSCs which were washed out with PBS and cultured in 7th medium.   
 
3.2.3 Culture of MSCs 
The culture of MSC was set in 7th medium at an initial density of 1x104 cells/cm2. The 
cells were passaged at 80-95% confluence after 3-7 days depending on the growth 
rate. The cells were passaged by removing the old medium, washing the cells once 
with PBS and adding 1.5 ml of 0.25% Trypsin-EDTA. After incubation at 37 °C for 3-5 
min, the MSCs were fully dissolved from the cell surface and the proteolytic trypsin 
cleavage was stopped by adding 2 ml of R10 medium. The cell suspension was 
centrifuged at 400 x g for 7 min, the cell pellet was dissolved in 1 ml 7th medium and 
the cell number was determined by Neubauer chamber. Subsequently the cells were 
seeded into a new culture flask provided with fresh 7th medium at 1 x 104 cells/cm2.  
 
3.2.4 Culture of HSCs 
The CD34+ cells from cord blood and mobilized peripheral blood were grown in long-
term bone marrow culture medium (LTBMC medium). The LTBMC medium was 
sterile filtered and stored at -20 °C. The medium was centrifuged once at 1600 g for 
10 min at room temperature before usage. The supernatant was used for the HSC 
culture.  The culture was set in 12- and 24-well format at 37 °C and 5% CO2.  
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3.2.5 Culture of lymphoblastoid cell line 
The GM12878 cells derived from human lymphoblastoids were grown in RPMI1640 
medium provided with 25% FBS, as previously indicated. The cells were seeded at a 
concentration > 200,000 cells/ml. The culture was set in T25 flaks at 37 °C and 5% 
CO2. Cells were passaged at a density of 200,000 – 500,000 cells/ml.  
 
3.2.6 Carboxyfluorescein succinimidyl ester staining 
To investigate the proliferation behavior of HSCs after seven days of in vitro co-
culture with MSCs. The HSCs were stained with a fluorescent dye prior to the co-
culture. The compound carboxyfluorescein diacetate succinimidyl ester (CFDA-SE) 
diffuses through the cell membrane and is subsequently cleaved by the intracellular 
esterases into the fluorescent carboxyfluorescein succinimidyl ester (CFSE). The 
CFSE molecules bind irreversibly to the amines of the free lysine chains which get 
divided homogeneously into two daughter cells after each cell division resulting in a 
decrease of the fluorescent signal by 50%.   
Cord blood HSCs were washed once in MACS buffer (580 x g, 7 min, room 
temperature) and resuspended in 750 µl PBS with 0.1% FCS. An aliquot of 250 µl 10 
µM CFDA-SE was added to the cells and incubated at 37 °C for 10 min. To stop the 
reaction, 7 ml ice cold RPMI 1640 provided with 10% FCS was added to the cells and 
incubated on ice for 5 min. Subsequently, the cells were washed twice in MACS 
buffer (580 x g, 7 min, RT), resuspended in long-term bone marrow culture medium 
(LTBMC) and cultured for up to seven days. An aliquot of the cells remained 
unstained and was kept separately in LTBMC. This was used as auto-fluorescent 
control of the flow cytometry analysis.  
 
3.2.7 Propidium iodide staining  
Cells measured by flow cytometry were stained with propidium iodide to evaluate cell 
viability. Propidium iodide is a membrane impermeant compound which is generally 
excluded from viable cells. In apoptotic and necrotic cells with permeant and impaired 
membranes, the fluorescent dye binds to DNA by intercalating between base pairs. 
Samples resuspended in MACS buffer were incubated with 1-2 µl propidium iodide at 
room temperature for 15 min prior to flow cytometry measurement.  
3. Materials and Methods 
 
53 
 
3.2.8 Cryo-preservation of the cells 
MSCs and cell lines were stored in -80 °C freezer and subsequently in liquid nitrogen. 
Each aliquot of 1x106 MSCs was resuspended in 500 µl 7th culture medium, 400 µl 
FCS and 100 µl DMSO in a cryovial. The vials were transferred to a Mr. Frosty 
freezing container provided with isopropanol and stored at -80 °C for 24 h. Frozen 
cells were maintained in liquid nitrogen for long-term storages. 
3.2.9 Antibody staining of HSCs 
The cells were counted by Neubauer chamber and washed in MACS buffer. 
Subsequently the cells were transferred into FACS tubes and washed again in MACS 
buffer (580 x g, 6 min, room temperature). The supernatant was discarded and a 
residual volume of 100 µl remained for antibody staining. For every fluorochrome, an 
unstained control to determine the autofluorescence of the cells was prepared. If 
multiple antibodies were used in parallel, fluorescent compensation controls were 
prepared for each fluorochrome by staining the cells using the corresponding 
antibody. The probes were stained at concentrations recommended by the 
manufacturer at 4 °C for 30 min. The cells were washed once in MACS buffer at 580 
x g for 6 min. The remaining cell pellet was resuspended in 200 µl MACS-buffer. 
Prior to flow cytometry measurement, an aliquot of 1 µl propidium iodide was added 
to stain the apoptotic and necrotic cells.  
3.2.10 Co-culture of HSCs and MSCs 
A co-culture of HSCs and MSCs were used as a model to study interactions between 
the stem cell niche and HSCs in vitro. HSCs were cultured on a monolayer of MSCs 
for seven days.  
3.2.10.1 Preparation of MSC feeder layer  
An initial amount of 3x104 MSCs per 24-well or 5x104 MSCs per 12-well were seeded 
in 500 µl or 1 ml 7th maintenance medium. After overnight incubation at 37 °C, the 
cells became adherent to the plastic well surface. The monolayer of cells were either 
kept in the maintenance medium or differentiated into adipogenic and osteogenic 
differentiated MSCs for 21 days obtaining undifferentiated MSCs, adipgenically 
differentiated MSCs (ADI-MSCs) and osteogenically differentiated MSCs (OST-
MSCs), respectively.  
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3.2.10.2 Initiation and termination of the co-culture  
To initiate the HSC-MSC co-culture, the MSC media were removed and the MSC, 
ADI-MSC and OST-MSC monolayers were washed twice with 1 ml PBS for each well. 
To each 24-well of confluent feeder cell layer, 1-2.5x105 CD34+ cells resuspended in 
500 µl long-term bone marrow culture medium (LTBMC) were added and co-cultured 
for seven days at 37 °C, 5% CO2. To analyze the HSCs after seven days co-culture, 
the HSCs were separated physically from the MSCs by repeated pipetting of the 
culture medium. The HSCs were subsequently stained with fluorescent antibodies 
ready for flow cytometric analysis. To investigate the effects of indirect contact 
between HSCs and MSCs, co-culture experiments in a transwell setup were carried 
out. For each transwell insert containing a polycarbonate membrane with a pore size 
of 0.4 µm, HSCs were cultured in 100 µl LTBMC. The monolayers of MSCs, ADI-
MSCs and OST-MSCs were cultured in 400 µl LTBMC per 24-well. 
 
3.2.11 Differentiation of MSCs 
Osteogenic and adipogenic differentiation protocols of MSCs were adapted from 
Pittenger et al. (Pittenger et al., 1999). An initial amount of 30,000 MSCs in 0.5 ml 7th 
medium were seeded to each 24-well until 60% confluence was obtained. 
Subsequently, the 7th maintenance medium was substituted by adipogenic or 
osteogenic differentiation medium to induce the respective differentiation of the 
MSCs. The cells were cultured in differentiation medium for 21 days with medium 
changes every three days.  
 
3.2.12 Staining of triglycerides in adipoblasts 
The lipophilic dye BODIPY at a concentration of 10 µg/ml was added to 
adipogenically differentiated MSCs previously fixed with 4% paraformaldehyde (PFA) 
in a 24-well plate. After 20 min incubation at room temperature in absence of light, 
the cells were washed once by PBS. The stained cells were investigated by 
fluorescent microscopy in combination with DAPI nuclear staining.  
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3.2.13 Staining of hydroxyapatite in osteoblasts 
Osteogenically differentiated MSCs form bone-like inorganic hydroxyapatite which 
was stained with antibody-based OsteoImage Assay. An aliquot of 0.5 ml diluted 
staining antibody from OsteoImage Assay Kit (Lonza) was added to osteogenically 
differentiated MSCs previously fixed with 4% PFA in a 24-well plate. After 30 min 
incubation at room temperature in absence of light, the cells were washed three 
times with the washing buffer provided by the OsteoImage Assay Kit. The stained 
cells were subsequently investigated by fluorescent microscopy in combination with 
DAPI nuclear staining.  
 
3.2.14 ATAC-sequencing  
 
3.2.14.1 Preparation of lymphoblastoid cells  
The workflow for ATAC-seq library preparation was established using the human 
lymphoid cell line GM12878 in order to compare our sequencing results with the 
reference dataset published by Buenrostro et al. (Buenrostro et al., 2013). The 
GM12878 cells were cultured as previously described. For our library preparation, an 
aliquot of 50,000 viable cells in exponential growth phase was harvested and quality 
checked by FACS sorting using propidium iodide life and death staining. 
 
3.2.14.2 Preparation of MSCs 
Primary mesenchymal stromal cells derived from healthy individuals of different ages 
were expanded in 7th culture medium. The cells were seeded into two 12-well plates 
at passage four. One plate was used for subsequent ATAC-seq workflow and the 
other plate for fluorescent microscopy imaging. The cell number in each well was 
determined by DAPI nuclear staining of the imaging plate. For each strain, three wells 
were imaged to determine the cell number using automatized cell counting (ImageJ). 
The adherent cells were harvested using 400 µl accutase, later neutralized using 600 
µl R10 medium. From the suspension, 50,000 cells were taken for ATAC-seq library 
preparation. 
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3.2.14.3 Tagmentation  
An aliquot of 50,000 cells in single-cell suspension was washed once with 200 µl ice-
cold PBS at 500 x g, 4 °C for 5 min. The cell pellet was subsequently resuspended in 
50 µl tagmentation mix containing 2.5 µl TDE, 25 µl 2x TD Buffer (both from Nextera 
kit), 22 µl nuclease-free H2O and 0.5 µl 1% digitonin. The suspension was incubated 
at 37 °C for 30 min. The reaction mixture was purified using Qiagen PCR purification 
kit. The MinElute column was eluted with 12 µl elution buffer. The DNA concentration 
was measured by the Qubit system. 
  
3.2.14.4 PCR-amplification of the library 
The DNA mixture from the previous tagmentation step was mixed with 10 µl 
nuclease-free H2O, 2.5 µl of 25 µM Nextera Indexing Primer i7, 2.5 µl of 25 µM 
Nextera Indexing Primer i5 and 25 µl of NEBNext High-Fidelity 2x PCR master mix. 
The PCR was run using the following program: 72 °C, 5 min; 98 °C, 30 sec; cycle 
start:  98 °C, 10 sec; 63 °C, 30 sec; 72 °C, 1 min, cycle close (run 5 cycles). To 
reduce GC and size bias in PCR, the remaining number of PCR cycles (N) was 
determined using a real-time PCR side reaction, allowing a termination of 
amplification prior to saturation. The additional cycles of PCR was run using the 
following program: 98 °C, 30 sec; cycle start:  98 °C, 10 sec; 63 °C, 30 sec; 72 °C, 1 
min, cycle close (run N cycles). 
 
3.2.14.5 Real-time PCR 
The appropriate degree of PCR amplification was determined using real-time PCR 
which prevents the prepared ATAC-seq DNA library from containing too many 
multiplicated fragments. An over-amplification of the tagmented library would also 
lead to GC and fragment size bias caused by PCR. Using real-time PCR, the 
detection of the PCR amplification products in real time after every cycle is based on 
the fluorescent signal of the SYBR Green Dye I which intercalates into the double-
stranded DNA. The SYBR Green Dye I is a cyanine dye which forms a complex with 
DNA and is excited by a laser beam at 522 nm. The measured fluorescence 
increases proportionally with the amplified products. After the amplification, an 
analysis of the real-time PCR amplification plot was performed. 
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For each sample, a real-time PCR master mix was prepared by adding 0.9 µl of 10x 
SYBR Green I Fluorescent Dye to 5 µl of NEBNext High Fidelity 2x PCR master mix 
and 3.6 µl of nuclease-free H2O. An aliquot of 9.5 µl master mix was added to 5 µl of 
the previously amplified DNA library together with each 0.25 µl of the Nextera 
indexing forward and reverse primers used in previous steps. The real-time PCR was 
run using the following program: 98 °C, 30 sec; cycle start:  98 °C, 10 sec; 63 °C, 30 
sec; 72 °C, 1 min, cycle close (run 25 cycles). As described by Buenrostro et al., the 
additional number of cycles N was determined as the cycle number that corresponds 
to one-third of the maximum fluorescent intensity on the linear Rn versus cycle plot 
(Buenrostro et al., 2013). 
 
 
3.2.14.6 Agarose gel electrophoresis  
For each gel, 1.08 g agarose in 100 ml 1 x TBE-Puffer was melted and poured into a 
BioRad gel chamber. To stain the gel, 4 µl of fluorescent nucleic acid gel dye were 
added. The 45 µl PCR product was mixed with 9 µl of 6 x loading dye and run at a 
constant voltage of 120 V for one hour. An aliquot of 8 µl 100 bp DNA plus ladder 
was run on the side of the samples. Gel pieces from right above the primer dimer 
band (ca. 100 bp) to 1 kb was cut and isolated with a scalpel on a blue light 
transilluminator at 470 nm. DNA was extracted using Qiagen gel extraction kit. The 
agarose gel slice of every sample was divided equally into two pieces and eluted with 
two MinElute columns. The concentration of the libraries was measured by Qubit 
system and the quality of the libraries was assessed by BioAnalyzer.  
 
3.2.14.7 Assessment of ATAC-seq library quality 
The quality of the prepared ATAC-seq DNA libraries was assessed using 
BioAnalyzer 2100 High Sensitivity DNA Assay according to descriptions of the 
manufacturer. This analysis method to test the quality and quantity of DNA libraries 
on a chip is based on the principle of capillary electrophoresis. DNA fragments of 
different lengths are separated according to their sizes along an electrical field in 
micro-capillary channels. The DNA fragments of different lengths are detected by a 
fluorescent sensor. For each prepared ATAC-seq library, an aliquot of 1 µl (up to 50 
ng) was loaded on to the BioAnalyzer chip. A BioAnalyzer profile representing the 
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fragment size distribution of the loaded ATAC-seq library was acquired using the 
Agilent 2100 BioAnalyzer Software.  
 
3.2.14.8 Measurement of DNA concentration 
The concentrations of the ATAC-seq libraries were determined on a Qubit 
fluorometer. The Qubit system is based on the principle that a fluorescent dye has 
very low fluorescence until it binds to DNA. Upon intercalation between DNA bases, it 
becomes intensely fluorescent enabling the measurement of the sample DNA 
concentration on a fluorometer (Schweitzer et al., 2003). For each sample, 1 µl was 
added to the buffer and dye provided by the Qubit DNA HS Assay kit according to 
descriptions of the supplier.  
 
3.2.14.9 Deep sequencing of ATAC-seq library samples 
The next-generation sequencing of the ATAC-seq libraries was carried out at the 
Genome Core Facility of EMBL Heidelberg. Up to eight samples were multiplexed in 
equal molarity and run on Illumina NextSeq 500 Platform to obtain 75 bp paired-end 
sequencing reads (ca. 120-150 million reads per sequencing lane). The first sample 
batch was sequenced on a Illumina HiSeq2000 machine with 50 bp single-end read 
lengths and 50 million reads per replicate.  
 
3.2.14.10 Alignment and peak calling 
Before alignment to the human reference genome the ATAC-seq sequences were 
quality-checked using FastQC focusing on criteria such as total number of reads, 
sequencing length distribution, sequence quality per base and duplication level. 
Subsequently, adaptor sequences were trimmed off the 75 bp paired-end reads 
using the software tool Trimmomatic. The sequencing reads were mapped to the 
hg19 reference human genome using Bowtie2. PCR duplicates were removed using 
Picard tools. For the mapped reads, a mapping score MAPQ was assigned. A cutoff 
(MAPQ<10) was taken to filter out reads with low mapping quality. Reads mapping to 
the mitochondrial genome as well as those reads having insertions or deletions were 
removed. The ATAC-seq peaks were subsequently called using the software 
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package MACS2 (Model-based Analysis of ChIP-Seq) with parameters “–nomodel –q 
0.001”.  
 
After peak calling, the quality of the sequenced libraries was further checked using 
the transcription start site (TSS) enrichment score (Figure 10). This is defined as the 
ratio between ATAC-seq signal proximal to TSS (+/- 2kb window) and ATAC-seq 
signal distal to TSS (1kb window). A TSS enrichment score of 7 was used as an 
empirical threshold for signal-to-noise ratio. The Bioconductor package DiffBind was 
used to extract the read counts falling in a consensus set of peaks, which was 
defined as those peaks having signal for at least two different individuals per samples. 
To detect significant changes upon aging across sequencing samples, a differential 
peak analysis was carried out using DESeq2 with linear regression (Anders et al., 
2012). The size factors were calculated using “median ratio method”. We tested the 
null hypothesis that the signal remains unchanged with age using the model 
“enzyme_batch_and_sex + donor age”. The term “enzyme_batch_and_sex” accounts 
for batch and gender effects in ATAC-seq profiles. Statistical significance was tested 
according to a Wald test and p-values corrected for multiple testing with Benjamini-
Hochberg. We took adjusted p-value <=0.05 as significant for all of the subsequent 
analyses. 
 
  
 
Figure 10 An average enrichment score was calculated based on annotated transcription start 
sites. The enrichment score is the ratio of 4 kb window around transcription start sites and ATAC-seq 
signal distal to transcription start sites of protein coding genes (1 kb window). Empirically, a threshold 
enrichment score of 7 is used for quality checks of the dataset. The open chromatin profile at locus of 
transcriptional repressor CTCF (CCCTC-binding factor) was shown.   
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4. Results 
4.1 Immnunophenotypic characterization of the human bone 
marrow 
4.1.1 Separation of bone marrow mononuclear cells into six cell 
types 
 
Within the overarching goal of the collaborative working group in elucidating the 
molecular mechanisms of aging in human bone marrow, this project focuses on the 
age-associated alterations in human bone marrow microenvironment, i.e. the 
hematopoietic stem cell niche. Although the role of the marrow niche in maintaining 
the stemness of HSCs has been recognized, a molecular understanding of the 
interactions between stem cells and the marrow niche during the aging process 
remains elusive so far (Köhler et al., 2009; Florian et al., 2012).  
As part of the large-scale SystemAge project, bone marrow samples from 59 healthy 
human individuals between ages of 20 and 60 were collected. The age-associated 
changes were investigated on transcriptome and proteome levels using shotgun 
mass spectrometry proteomics and RNA sequencing. The project has been approved 
by the Research Ethics Board of the University of Heidelberg and written informed 
consent was obtained from every human subject.  
As described in the method section 3.1.1.2, bone marrow aspirates were taken by 
puncture of the iliac crest. The mononuclear cell fraction was subsequently isolated 
by FICOLL density gradient centrifugation. From each sample, the CD34+ cells were 
isolated as the population with enriched hematopoietic stem cells (HSCs). CD34 is a 
common marker for hematopoietic stem cells. It is a glycoprotein which functions as a 
cell adhesion factor mediating the attachment of stem cells to the bone marrow 
extracellular matrix (Sidney et al., 2014). Out of the CD34- cell population, 
granulocytic precursors (GRA) were defined by the medium expression of CD45 and 
high granularity reflected in the high expression of the side scatter (SSC-A). Erythroid 
precursors (ERP) was the CD45- population. Lymphocytes and precursors (LYM), 
monocytes, macrophages and precursors (MON) showed high expression levels of 
CD45; CD45 is a common leukocyte antigen that belongs to the protein tyrosine 
phosphatase (PTP) family. PTPs regulate various cellular processes including cell 
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growth and differentiation (Tonks, 2006). The MON population was further defined by 
the monocyte-specific cell surface marker CD14 (Figure 11). CD14 is a specific 
marker for monocytes, macrophages and precursors (MON). The cell type MSC was 
isolated in vitro by plastic adherent growth in the maintenance culture medium from 
the mononuclear cell fraction. The isolated cell types were subjected to further 
downstream shotgun proteomics and RNA sequencing analysis.   
 
Figure 11 Overview of the experimental workflow and cell types used in the study. Bone marrow 
aspirates from healthy human individuals were separated by FICOLL gradient centrifugation into 
mononuclear cell fraction.  Hematopoietic stem cells (HSC), lymphocytes and restricted precursors 
(LYM), monocytes, macrophages and restricted precursors (MON), granulocytic precursors (GRA) and 
erythroid precursors (ERP) were isolated by fluorescence-activated cell sorting (FACS). The live cell 
population was first separated into HSCs and non-HSCs by the expression level of CD34. The non-
HSC population was subsequently sorted into LYM, MON, GRA and ERP by side scatter and 
expression levels of CD45. The MON population was additionally constrained by the expression of 
CD14. MSCs were isolated and expanded by plastic adherent growth in vitro.  
The bone marrow donors were recruited over a time period of three years. Out of the 
total evaluable 59 donors, 24 were between ages 20 and 30; 13 were between 31 
and 40; 12 were in the age group between 41 and 50 and 10 between ages 51 and 
60. The stronger concentration of donors in the younger age groups is due to the fact 
that younger individuals were more willing to donate their bone marrow samples 
(Figure 12A).  
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Figure 12 A general overview on the age distribution and the quality of isolated bone marrow 
samples. (A) The age and gender distribution of hematopoietic stem cells (HSC), lymphocytes and 
restricted precursors (LYM), monocytes, macrophages and restricted precursors (MON), granulocytic 
precursors (GRA), erythroid precursors (ERP) and mesenchymal stromal cells (MSC) derived from 59 
human individuals are shown. Each section represents one cell type as indicated at the beginning of 
the circle. The age of the donors is indicated at the periphery of the circle. The gender of the donor is 
shown in green (male) and red (female). (B) The technical sorting purity of FACS-isolated bone 
marrow cells is shown by box plots. 
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4.1.2 Technical purity of sorted cell samples 
 
For the intepretation of our downstream proteomics and transcriptomics results, it is 
essential to achieve a high degree of purity of the sorted cell types. Each time after 
FACS sorting, the purity of the separated cell populations was determined by 
remeasuring a small aliquot of sorted cells on the FACS machine using the same 
detection conditions. The purity of the sorted probe was calculated by the analysis of 
the post-sorted FACS data. The majority of the sorted samples have a purity above 
90% as shown in figure 12B. For most of the sorted cell types, a major source of 
impurities was found to be erythroid progenitors and erythrocytes (ERP) (Figure 13). 
Due to their relatively small size, these cells tend to adhere on the surface of larger 
cells in the mononuclear cell fraction. Apart from ERP, cells of the mononuclear cell 
population outside of the sorting gates were another major source of impurity (Figure 
13). The high sorting purity of the the isolated cell populations was confirmed by the 
subsequent proteomic measurements. In the proteomics dataset, all established cell 
type-specific markers could be identified in the corresponding cell type sorted by 
FACS.  
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Figure 13 Sources of contamination in the FACS-sorted cell types. The contaminations for the 
FACS-sorted cell types hematopoietic stem cells (HSC), lymphocytes and restricted precursors (LYM), 
monocytes, macrophages and restricted precursors (MON), granulocytic precursors (GRA) and 
erythroid precursors (ERP) were determined. The sorted cell populations were shown in blue whereas 
sources of impurities were shown in grey. The box “others” indicated mononuclear cells apart from the 
gated cell types. The thickness of the edges between sorted cell population and source of impurities 
indicated the relative contribution of each source to the total impurity.  
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4.1.3 Individual variability in relative percentages of the major bone 
marrow constituents 
 
To verify whether there might be alterations in the cellular composition of human 
bone marrow upon aging, we studied changes in the bone marrow constituent cells 
with respect to age.  
The flow cytometry data generated during FACS isolation of the five cell types HSC, 
LYM, MON, GRA and ERP were analyzed to determine the relative percentage of 
each cell type in the mononuclear cell fraction. As shown in figure 14A, 31.1% of the 
bone marrow mononuclear cells were ERP, which was the largest population. 
However, broad variations in the relative percentages (5.6% to 69.1%) were 
observed among individual donors. Another 29.2% of the mononuclear cells 
consisted of LYM. The median relative percentage of MON in the mononuclear cell 
population was at 9.9% and the median relative percentage of GRA was 14.8%. The 
smallest fraction in the mononuclear cell fraction was HSC, which was at 2.0% 
(Figure 14A). Taking the median percentages of the cell types together, the five cell 
types sorted by FACS constituted about 87% of the mononuclear cell fraction in the 
bone marrow niche. In conclusion, variations were observed among the relative 
percentages of each cell type in the mononuclear cell population.  
As a second step, we determined if the observed variations are associated with the 
biological age of the donors. For all five cell types measured by flow cytometry, a 
linear correlation was tested. As shown by the coefficients of determination (R2), a 
linear correlation between the relative percentages in the mononuclear cell 
population with age was not observed (Figure 14A). In addition, a spearman test 
indicated that for each sorted cell type, the relative percentage does not correlate 
with the donor age (Supplementary Material, Table 2).  
Overall, the variability in relative percentages observed among individual samples 
might be of technical or biological origins. Depending on the location of the puncture 
and volume of the bone marrow aspirate, the cellular composition of the mononuclear 
cell fraction might vary between samples. To further investigate the biological 
variability among individuals, a larger cohort with more samples from elderly donors 
would be required for statistical correlation tests with age.  
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4.1.4 Individual variability in relative cell size and granularity of the 
major bone marrow constituents  
 
To investigate if the relative size and granularity of the samples vary between 
individual donors, the forward and side scatter properties of the FACS-sorted cells 
were studied. As described in the method section, the forward scatter is a measure 
for the relative size of a cell, whereas the granularity of the cell is reflected by the 
side scatter in flow cytometry (Givan, 2004). The knowledge about sample variability 
in cell size is e.g. useful for later normalization efforts of the downstream proteomics 
dataset. Fold changes in protein abundance can be e.g. put in relationship with the 
relative changes of the cell size to better interpret the experimental data.    
Since the cohort of samples was acquired over a period of three years, the LYM 
population was used as an internal standard due to its dense cell population in order 
to compare between flow cytometry measurements. Changes in forward and side 
scatters of HSC, GRA, MON and ERP were investigated in relationship to the LYM 
population. As indicated in figure 14B and C, variations in cell size as well as cell 
granularity were observed for all four cell types. To investigate if the sample 
variations were correlated with the age of the donors, a linear correlation was tested. 
As shown by the coefficients of determination (R2) in figure 14B and 14C, a linear 
correlation between the relative cell size and granularity with age was not observed 
(Figure 14B, 14C). In addition, a spearman test was carried out to study if the size 
and granularity of the sorted cell types are correlated with donor age. For all sorted 
cell types, there was no correlation between the relative cell size and granularity with 
age (Supplementary Material, Table 2).  
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Figure 14 Relative percentages, cell size and granularity of major bone marrow constituents 
are not correlated with age. (A) The relative percentages of cell types HSC, LYM, MON, GRA and 
ERP in the mononuclear cell population were determined based on the flow cytometry data generated 
during the sorting process. The distribution of the relative percentages in each cell type is shown. The 
numbers of the analyzed samples are n=35 for HSC, n=45 for LYM, n=40 for MON, n=44 for GRA and 
n=45 for ERP. (B) The relative cell sizes reflected by the forward scatter of the flow cytometry data 
were determined for HSC, MON, GRA and ERP while using the LYM population as a standard. The 
numbers of samples analyzed are n=33 for HSC, n=40 for MON, n=44 for GRA and n=43 for ERP. (C) 
In analogy, the relative cell granularity reflected by the side scatter was determined based on the flow 
cytometry data. The numbers of samples analyzed are n=33 for HSC, n=40 for MON, n=44 for GRA 
and n=43 for ERP. R2, coefficient of determination between donor age and relative percentage, cell 
size and cell granularity, respectively.  
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One phenotype generally observed in aged HSCs is the skewed differentiation 
potential towards myeloid lineage. Aged HSCs tend to differentiate more into cells of 
myeloid lineage, whereas the output of lymphoid-lineaged cells is decreased 
(Beerman et al., 2017). The lymphoid to myeloid lineage skewing might be caused by 
changes in HSC differentiation or by altered proliferation of myeloid and lymphoid 
precursors (Geiger et al., 2013; Beerman et al., 2017). Following this hypothesis, 
changes in the relative percentages of myeloid (MON, GRA, ERP) and lymphoid cells 
(LYM) were investigated in relation to each other. As indicated by figure 15A, no 
correlation was observed between the myeloid to lymphoid ratio with the age of the 
sample donors. The myeloid-to-lymphoid ratios normalized by the concentration of 
mononuclear cells were plotted against donor age in figure 15B, no correlation 
between the normalized myeloid-to-lymphoid ratios with age was observed as well 
(Figure 15B). Additionally, Spearman tests indicated that there is no correlation 
between the myeloid-to-lymphoid ratios and donor age (Supplementary Material, 
Table 1).   
Overall, no correlation with age was observed for the relative percentages, cell size 
and granularity of the bone marrow constituent cells. The variations among the 
samples might be of technical or biological origins. A larger cohort with more samples 
would be required for further statistical correlation tests with age.  
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Figure 15 Ratios between relative percentages of myeloid and lymphoid cells in the 
mononuclear fraction are not correlated with the biological age of the donors. (A) The myeloid-
to-lymphoid ratios (ERP, GRA and MON versus LYM) were determined based on the flow cytometry 
data generated during the sorting process. No correlation between the myeloid-to-lymphoid ratios with 
age was observed. (B) The myeloid-to-lymphoid ratios normalized by the concentration of 
mononuclear cells were plotted in relationship with age. No correlation between the normalized 
myeloid-to-lymphoid ratio with age was not observed. R2, coefficient of determination between donor 
age and myeloid-to-lymphoid lineage ratios.  
 
4.2 Differential HSC-supportive potential of MSCs, adipogenically 
differentiated MSCs and osteogenically differentiated MSCs 
 
Among the six cellular components of the bone marrow characterized in this study, 
the cell type MSC interacts via cell surface receptors such as integrin beta 1 with the 
HSCs (Walenda et al., 2010). MSCs have been reported to promote cell proliferation 
as well as maintenance of HSC stemness ex vivo. Based on this property, the 
interactions between the hematopoietic stem cells (HSCs) and the niche were 
studied in vitro using a co-culture system of CD34+ HSCs and MSCs. It was shown 
by previous studies that aging MSCs in vivo possess increased potential towards 
adipogenic differentiation which might be responsible for the reduced potency of the 
MSCs to support hematopoiesis with age. We have therefore examined the 
supportive potentials of adipogenically differentiated MSCs (ADI-MSCs) which might 
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be responsible for the reduced potency of the MSCs to support hematopoiesis with 
age (Lee et al., 2014; Marie, 2014). In this section, the in vitro supportive niche 
functions of undifferentiated MSCs, adipogenically differentiated MSCs (ADI-MSC) 
and osteogenically differentiated MSCs (OST-MSC) were studied.   
 
4.2.1 Morphological characterization of MSCs 
 
The MSCs in early passages (e.g. passage 0) showed a homogeneous, fibroblast-
like morphology, whereas MSCs at higher passages (e.g. passage 7) became more 
heterogeneous, and ultimately stopped proliferation (Figure 16A). The adipocytes 
derived from MSCs exposed for 21 days in vitro to differentiation medium contained 
extensive intracellular lipid vesicles which were stained by the fluorescent dye 
BODIPY. The fluorescent microscopy image of the BODIPY-stained adipocytes was 
shown in figure 16B. In analogy, the osteoblasts were derived from MSCs exposed to 
differentiation medium at high calcium concentration. The OST-MSCs secret 
inorganic hydroxyapatite which forms precipitates on plastic surface. The 
hydroxyapatite of OST-MSCs was stained by an antibody-based assay OsteoImage. 
The fluorescent microscopy image of the OsteoImage stained OST-MSCs was 
shown in contrast to ADI-MSCs and MSCs in figure 16B. 
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Figure 16 Morphological characterization of MSC. (A) MSCs at higher passages are more 
heterogeneous and ultimately stop proliferation. Representative light microscopy images of MSCs at 
early (passage 0) and late passage (passage 7) were shown. (B) Under high glucose adipogenic 
differentiation conditions, the MSCs showed characteristics of adipocytes after 21 days of in vitro 
culture. Under high calcium osteogenic differentiation conditions, the MSCs showed characteristics of 
osteoblasts after 21 days of in vitro culture. The triglycerides in adipogenically differentiated MSCs 
(ADI-MSCs) were characterized by BODIBY staining imaged by fluorescent microscopy. The secreted 
inorganic hydroxyapatites by osteogenically differentiated MSCs (OST-MSCs) were stained with 
antibody-based OsteoImage Assay.  
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4.2.2 Morphological characterization of HSCs 
 
The morphology of CD34+ HSC population was characterized by phase contrast and 
fluorescent microscopy. Freshly isolated HSCs were of a round shape and around 10 
µm diameter in size (Figure 17A). The CD34 marker is a trans-membrane 
glycoprotein on the cell surface (Figure 17B). As indicated by the antibody-based 
fluorescent staining, the distribution of the CD34 antigen on the cell membrane was 
uneven (Figure 17B). Upon in vitro culture with MSCs, the cell morphology of HSCs 
became heterogeneous and showed both around and an elongated shape (Figure 
17C) (Giebel et al., 2004; Freund et al., 2006). The co-culture with MSCs promotes 
proliferation and maintenance of the CD34+ population, whereas without feeder cells 
the CD34+ population decreases rapidly (Walenda et al., 2010). The in vitro co-
culture system serves as a surrogate model to study the cross-talks between HSCs 
and the bone marrow niche (Walenda et al., 2010). 
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Figure 17 Microscopy images of CD34+ HSCs. (A) Phase-contrast microscopy image of cord blood 
HSCs. The cells showed a round and oval shape. (B) Fluorescent microscopic images of CD34. The 
nuclei of the HSCs were stained by DAPI (blue). The CD34 antigen on the cell surface was stained by 
fluorescent antibody (red). (C) Microscopic images of HSC-MSC co-culture. HSCs isolated from 
mobilized peripheral blood (left) and cord blood HSCs (right) reside on the surface of adherent MSCs. 
Microscopy images taken by R. Saffrich, University Hospital Heidelberg.   
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4.2.3 Co-culture of CD34+ HSCs with MSCs, adipogenically 
differentiated MSCs and osteogenically differentiated MSCs  
 
Previous studies suggested that the increase in adipose tissue might be due to 
enhanced adipogenic differentiation of MSCs with age (Tuljapurkar et al., 2011; Marie, 
2014). The goal of this experiment is to study the impact of differentiation on the 
supportive potentials of MSCs for the proliferation and stemness of HSCs.  
The MSCs were therefore differentiated into adipogenically differentiated MSCs (ADI-
MSCs) and osteogenically differentiated MSCs (OST-MSCs) during 21 days in vitro 
culture in the respective adipogenic and osteogenic differentiation medium (Figure 
18). HSCs derived from human cord blood were subsequently co-cultured either 
without MSCs, with MSCs, ADI-MSCs or OST-MSCs (Figure 18). The distribution of 
proliferated HSCs after seven days of co-culture was tracked by carboxyfluorescein 
succinimidyl ester (CFSE) staining (Figure 18). CFSE is a fluorescent dye whose 
signal decreases by 50% after each cell division. By analyzing the HSCs on a flow 
cytometer after seven days co-culture, the division history of the HSC population was 
determined (Figure 18).  
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Figure 18 Experimental setup of the HSC-MSC co-culture system. (A) HSCs were stained with the 
cytoplasmic dye CFSE prior to seven days co-culture. The CFSE fluorescent signal decreases by 50% 
after each cell division. (B) The MSCs were first differentiated into ADI-MSCs and OST-MSCs or 
maintained undifferentiated. CFSE-labeled HSCs were subsequently co-cultured with ADI-MSCs, 
OST-MSCs or MSCs for seven days. The proliferation and stemness of co-cultured HSCs were 
measured by flow cytometry. 
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The percentages of cord blood HSCs that have undergone one, two, three, four, five 
and above five divisions after seven days of co-culture with MSCs, ADI-MSCs, OST-
MSCs or without feeder cells are shown in figure 19A. We found that in total 74.7% of 
HSCs grown without feeder cells were at cell division steps above three (four, five 
and above five) (Figure 19A). Compared to HSCs grown on feeder cells, in total 99% 
of the HSCs grown on ADI-MSCs were at division steps above three, whereas in the 
cases of MSCs and OST-MSCs, those HSCs that had divided more than three times 
made up to 96.4% and 90.4% of the total HSC population, respectively. Based on the 
distribution of proliferated cells, one could confirm that MSCs as well as differentiated 
MSCs support the proliferation of HSCs in a co-culture setup. To further investigate 
the effects of differentiated MSCs on HSCs, the co-culture experiment was repeated 
using CD34+ HSCs from human mobilized peripheral blood. In line with our previous 
observations made on cord blood HSCs, the distribution of proliferated peripheral 
blood HSCs grown on MSCs and OST-MSCs were similar whereas HSCs grown on 
ADI-MSCs showed higher proliferation (Figure 19B). Interestingly, for HSCs grown on 
MSCs and OST-MSCs, there were more cells at division step four (23.4% on MSCs, 
22.5% on OST-MSCs) than at division step five (18.3% on MSCs, 16.6% on OST-
MSCs) after seven days co-culture, which differs from our previous findings using 
cord blood HSCs. Further experiments using mobilized peripheral blood HSCs are 
required to follow up on this observation. In conclusion, the stronger proliferation-
promoting effects of ADI-MSCs on HSCs were observed in cells both of cord blood 
and mobilized peripheral blood origin (Figure 19).  
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Figure 19 Distribution of proliferated cord and peripheral blood HSCs grown on MSCs, ADI-
MSCs, OST-MSCs and without MSCs after seven days co-culture. (A) Cord blood HSC 
proliferation increased upon co-culture with MSC, ADI-MSC and OST-MSC as compared to HSCs 
without feeder cells. HSCs grown on ADI-MSCs showed stronger proliferation compared to cells 
grown on MSCs and OST-MSCs. HSCs having undergone more than five divisions could not be 
distinguished from each other, as the CFSE intensity dropped to auto-fluorescence after five divisions. 
HSCs at division steps higher than five are thus indicated as “division >5”. (B) Peripheral blood HSCs 
grown on ADI-MSCs showed stronger proliferation compared to cells grown on MSCs and OST-MSCs.  
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In order to see to what extent the feeder cells MSCs, ADI-MSCs and OST-MSCs 
exert their functions to maintain HSCs in a quiescent state through direct cell-cell 
contact, we used trans-well filters to physically separate the HSCs from feeder cells 
only allowing free diffusion of cytokines. With this setup, the effects of direct cell-cell 
interactions and signaling through secreted cytokines on the physiology of HSCs 
were studied and compared. In accordance with our previous observations using the 
direct cell-cell contact setup, the majority of the HSCs had undergone more than 
three division steps. In total 99% of the HSC population grown on ADI-MSCs were at 
cell division steps above three. For HSCs grown on MSC and OST-MSCs, those that 
had divided more than three-times made up to 97% of the total cell population (Figure 
20). Comparing to our previous co-culture experiments with direct cell-cell contacts, 
HSCs grown in supernatants of MSCs and OST-MSCs showed stronger proliferation 
after seven days co-culture (Figure 20). This finding leads to the hypothesis that 
direct cell-cell contacts are required for MSCs and OST-MSCs to retain HSCs at 
lower proliferation. For ADI-MSCs, however, the lack of direct cell contact seems not 
to affect the proliferation of the HSCs suggesting that the supportive function of ADI-
MSCs for HSCs is exerted through secreted cytokines.  
 
Figure 20 Distribution of proliferated cord blood HSCs grown in supernatants of MSCs, ADI-
MSCs and OST-MSCs without direct cell-cell contacts after seven days co-culture. The majority 
of the HSCs had undergone more than three division steps. In total 99% of the HSC population grown 
on ADI-MSCs were at cell division steps above three. For HSCs grown on MSCs and OST-MSCs, 
those that had divided more than three-times made up to 97% of the total cell population. 
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4.2.4 Stemness of proliferated HSCs upon co-culture with MSCs, 
adipogenically differentiated MSCs and osteogenically 
differentiated MSCs 
 
To determine the maintenance potential of the different preparations of MSCs, we 
measured the CD34 expression level in cord blood HSCs after seven days co-culture 
either without MSCs, with MSCs, ADI-MSCs and OST-MSCs (Figure 21A). 
Compared to HSCs grown without feeder cells, the CD34 expression levels of co-
cultured HSCs were higher at division steps four, five and above five. The low CD34 
expression levels of HSCs grown without feeder cells after the fourth division 
suggested a loss of stemness (Figure 21A). Based on this result one could confirm 
that MSCs as well as differentiated MSCs are required for the maintenance of HSCs. 
The CD34 expression level of HSCs grown under all conditions decreased with 
increasing number of divisions. This finding suggests that despite the protective 
environment provided by the MSCs, the in vitro proliferation of HSCs is accompanied 
by the decrease of stemness. At division step four, HSCs grown on MSCs showed 
higher expression level of CD34 compared to cells grown on OST-MSCs. The CD34 
expression level of HSCs grown on ADI-MSCs was not indicated due to low 
percentage cells at this division step. At division step five, HSCs grown on MSCs, 
ADI-MSCs and OST-MSCs showed similar levels of CD34 expression. At division 
steps above five, despite the standard errors, the CD34 expression level of HSCs 
grown on ADI-MSCs was higher than the ones grown on other feeder cell types 
(Figure 21A). Similar results were obtained using HSCs derived from peripheral blood. 
At division step four, HSCs grown on MSCs and OST-MSCs showed similar levels of 
CD34 expression (Figure 21B). At division step five, the CD34 expression levels of 
HSCs grown on OST-MSCs and MSCs remained low (Figure 21B). The CD34 
expression level of HSCs grown on ADI-MSCs was higher which was not observed 
previously with HSCs from cord blood. At division steps above five, in line with our 
previous experiment using cord blood HSCs, peripheral blood HSCs grown on ADI-
MSCs showed a higher level of CD34 expression compared to HSCs grown on 
MSCs and OST-MSCs (Figure 21B). However, due to the variability of the sample 
sources, further experiments need to be carried out to confirm our preliminary 
findings.  
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In conclusion, these results demonstrate that MSCs, ADI-MSCs and OST-MSCs not 
only support the proliferation of HSCs, but also maintain their primitive 
immunephenotype over a number of cell divisions compared to HSCs grown without 
feeder cells. At division steps above five, HSCs grown on ADI-MSCs showed a 
higher level of CD34 expression compared to HSCs grown on MSCs and OST-MSCs 
(Figure 21).  
 
 
 
Figure 21 CD34 expression levels of cord and peripheral blood HSCs grown on MSCs, ADI-
MSCs, OST-MSCs and without MSCs after seven days of co-culture. (A) CD34 expression levels 
of cord blood derived HSCs at division steps four, five and above five are shown. HSCs grown on 
MSCs, ADI-MSCs and OST-MSCs maintained their primitive immunophenotype over a number of cell 
divisions compared to HSCs grown without feeder cells. (B) CD34 expression levels of peripheral 
blood derived HSCs at division steps four, five and above five are shown. HSCs grown on ADI-MSCs 
showed higher CD34 expression levels than HSCs grown on OST-MSC and MSCs at division steps 
five and above five. Experiments were performed in biological triplicates; standard errors are indicated 
by the error bars. 
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Using trans-well filters to physically separate the HSCs from feeder cells only 
allowing free diffusion of cytokines, the CD34 expression levels of cord blood HSCs 
grown without direct cell-cell contacts in the supernatants of MSCs, ADI-MSCs and 
OST-MSCs were studied (Figure 22). At division steps five and above five, the CD34 
expression level of HSCs grown on ADI-MSCs was higher than the ones grown on 
other feeder cell types. This finding leads to the hypothesis that ADI-MSCs are able 
to maintain the stemness of HSCs through secreted cytokines (Figure 22). Taking the 
results of proliferation into consideration, one can conclude that HSCs grown in the 
supernatant of ADI-MSCs possess a high rate of proliferation while still maintaining a 
high CD34 expression level.   
 
 
   
 
Figure 22 CD34 expression levels of cord blood HSCs grown in supernatants of MSCs, ADI-
MSCs and OST-MSCs without direct cell-cell contacts after seven days co-culture. CD34 
expression levels at division steps four, five and above five are shown. HSCs grown on ADI-MSCs 
showed higher level of CD34 expression than OST-MSC and MSCs at division steps five and above 
five. Experiments were performed in biological triplicates; standard errors are indicated by the error 
bars. 
 
 
 
 
 
4. Results 
 
83 
 
4.3 Chromatin accessibility landscape of aging MSCs 
 
To study the age-associated changes on chromatin levels in the human 
hematopoietic stem cell niche, the genome-wide chromatin accessibility assay ATAC-
seq was performed using MSCs from donors of different ages. In aging cellular 
systems, the general hypothesis is that the heterochromatin region of the genome 
loosens up while the euchromatin is hypermethylated at specific DNA loci (Booth et 
al., 2016).  In bone marrow derived MSCs, transcriptomic studies showed that the 
expression of many homeobox transcription factors including HOXA5, HOXB3 and 
HOXB7 are repressed upon aging. Moreover, the master regulator of adipogenesis 
PPARγ was repressed upon aging (Wagner et al., 2009). These findings were 
confirmed by a DNA methylation study which demonstrated that differences upon 
aging were observed in homeobox genes and genes involved in cell differentiation 
(Bork et al., 2010). However, the relationship between chromatin accessibility and 
aging in MSCs is not yet defined.  
ATAC-seq profiles chromatin accessibility genome-wide. By overlaying ATAC-seq 
with ChIP-seq data, Lara-Astiaso et al. provided a comprehensive model of 
chromatin dynamics during 16 stages of murine hematopoietic differentiation (Lara-
Astiaso et al., 2014). Moreover, ATAC-seq dataset generated in the primary CD4+ T 
cells revealed novel gender-specific elements that escape X chromosome 
inactivation (Qu et al., 2015). The ATAC-seq method initially published by Buenrostro 
et al. was developed for the GM12828 human lymphoid cell line grown in suspension, 
as datasets on multiple molecular levels were available for this cell line (Buenrostro 
et al., 2013). 
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4.3.1 Adaptation of the ATAC-seq protocol  
 
In order to establish this method in our lab, preliminary experiments were performed 
using the same GM12828 cell line as described in the published protocol (Buenrostro 
et al., 2013). During this process, different technical changes were made according to 
the local laboratory conditions. Subsequently, the workflow was applied to human 
primary MSCs. The ATAC-seq sample preparation consists of four major steps 
including cell culture, lysis and transposition, library amplification and purification, and 
deep sequencing (Figure 23).  
 
 
Figure 23 Workflow of ATAC-seq adapted to MSCs. The published protocol for the human 
lymphoblastoid cell line GM12828 was adapted to primary MSCs. The sample preparation pipeline 
consists of four major steps including cell culture (gray), lysis and transposition (orange), library 
amplification and purification (green), and deep sequencing (blue).  
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For each ATAC-seq sample, cells were harvested 24 h after the last passage. In the 
course of our test experiments, we found that the viability of the cells were crucial for 
the signal-to-noise ratio of the ATAC-seq dataset. A propidium iodide labeling 
ensured the cell viability to be higher than 95%. As the MSCs were grown on plastic 
surface, the adherent cells were counted by a DAPI nucleus staining followed by an 
automated cell counting (ImageJ) (Figure 23). For each library 50,000 cells were 
detached by the proteolytic enzyme accutase (Sigma-Aldrich). The cells were 
subsequently lysed by the non-ionic detergent digitonin. As digitonin can be used in 
combination with the Tn5 tagmentase, the one-step lysis and tagmentation was 
applied to the MSC samples. The nuclei were tagmented using 2.5 µl Tn5 
transposase. The tagmentation step is based on the principle of Tn5 transposase to 
randomly insert sequencing primers into open chromatin regions of the genome 
(Buenrostro et al., 2013). The ratio between the starting cell number and 
tagmentation enzyme affects the fragment size distribution of prepared libraries. In 
case of under-tagmentation, the majority of the tagmented DNA fragments are larger 
than 1,500 bp in size. This leads to lower coverage of the library as fragments larger 
than 1.2 kb do not cluster on the flow cell of the sequencer. The information encoded 
by the larger fragments is therefore lost by low sequencing yields. The tagmented 
DNA library was subsequently amplified by PCR. The number of amplification cycles 
N was determined by real-time PCR assay with the aim to avoid over-amplification 
resulting in large proportions of duplicated fragments in the library. To ensure proper 
quality of the ATAC-seq libraries prior to sequencing, the fragment size distribution of 
ATAC-seq libraries was routinely examined on BioAnalyzer. For the MSC samples, 
libraries were sequenced on an Illumina NextSeq500, with around 50 million reads 
per replicate. The libraries were sequenced 75 bp paired-end. The sequencing depth 
covers the human genome at about 2.3-fold.  
The fragment size distribution of the library shows that the majority of the DNA 
fragments consisted of short fragments less than 200 base pairs (Figure 24). These 
were mostly fragments from nucleosome depleted regions (NDR), where most 
regulatory elements reside. Similar to published data, we also observed a periodicity 
of nearly every 200 bp for the insert size distribution, suggesting that fragments were 
protected by different integer numbers of nucleosomes (Figure 24). The sequenced 
ATAC-seq DNA fragments also showed a periodicity of around 10 bp throughout the 
fragment size distribution. This periodicity is due to the so-called helical pitch of DNA. 
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Once a transposase inserts an adaptor into the open region of the chromatin, the 
regions 10 bp apart from the insertion site are protected from subsequent 
transposase attacks due to steric hindrance (Adey et al., 2010) (Figure 24).  
 
 
Figure 24 Insert size distribution of sequenced ATAC-seq library. Fragment size distribution of 
sequenced library showed nucleosome periodicity of approximately 200 bp indicating that the 
chromosomal DNA was protected by an integer number of nucleosomes. The periodicity of 
approximately 10.5 bp generated by the DNA helical pitch was due to steric hindrance of the inserted 
Tn5 transposase primers.  
 
 
4.3.2 Changes of chromatin accessibility in aging MSCs 
4.3.2.1 Overview of MSC samples 
 
ATAC-seq libraries were prepared from MSC samples derived from 16 individuals (12 
male and 4 female subjects). The age of the healthy donors ranged from 21 to 59 
years (Figure 26). By correlating the ATAC-seq profiles of the samples with donor 
age, alterations in chromatin accessibility upon aging were studied.  
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4.3.2.2 Quality checks of the dataset 
 
Prior to sequencing, the fragment size distribution of the ATAC-seq libraries was 
assessed using BioAnalyzer (Figure 25). The pattern of the nucleosome periodicity 
served as a major quality check for ATAC-seq libraries. An example of qualitatively 
good library was shown in contrast to a library which was excluded from sequencing. 
Both samples were prepared from the same MSC donor (Figure 25). A bird eye view 
on the fragment size distribution of all sequenced samples was shown in figure 26. 
The presence of the three major peaks in the ATAC-seq library was a requirement for 
further downstream processing of the sample.  
 
 
Figure 25 The library fragment size distribution serves as quality check prior to sequencing.  
An example of qualitatively good library (sample 1) is shown in contrast to a library which was 
excluded from sequencing (sample 2). Both replicates were prepared from the MSC donor #409 (age 
30, male). Sample 2 showed no nucleosome periodicity suggesting an unsuccessful tagmentation of 
the cells. The two peaks at 35 and 10,380 bp on the BioAnalyzer profiles are DNA markers (LM: lower 
marker; UM: upper marker). 
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After sequencing, an effective measure to assess the signal-to-noise ratio of our 
sequencing dataset is the transcriptional start site (TSS) enrichment score which was 
described in the human ENCODE project (Bernstein et al., 2012). After alignment of 
the sequencing reads to the genome, the number of reads mapped proximal to a 
reference set of TSS (in a +/- 2kb window) is divided by the number of reads mapped 
distal to the TSS (in a 1 kb window). A random mapping of the reads to the genome 
would therefore result in a TSS enrichment score of four (4 kb window proximal to 
TSS divided by 1 kb window distal to TSS). Using our test sequencing datasets, we 
found that an enrichment score higher than seven would allow us to identify enough 
ATAC-seq peaks to profile the open chromatin accessibility of the sample. A bird eye 
view for all samples is represented in figure 26. As indicated in figure 26, all 
sequenced samples showed an enrichment score higher than seven. The quality 
checks applied prior- and post-sequencing indicated that the current ATAC-seq 
dataset was reliable and of good quality to address questions on age-associated 
differences in chromatin accessibility.  
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Figure 26 Overview on the age and gender distribution as well as the quality of prepared ATAC-
seq libraries. ATAC-seq libraries were prepared from a cohort of 16 individuals. The gender of the 
donor was visualized by red (female) and green (male). The age of the donors was indicated at the 
periphery of the circle. The transcription start site enrichment scores of the samples were visualized by 
a color gradient ranging from 5 (brown) to 20 (blue) in the inner circle. For each MSC donor, two 
biological replicates were sequenced (rep1 & rep2). A bird eye view on the fragment size distribution 
of the sequenced libraries was shown by the box plot indicating the distribution of the three major 
peaks in ATAC-seq library.  
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4.3.2.3 Individual variations of mitochondrial DNA content  
 
As mitochondrial DNA is not associated with nucleosomes and hence gives rise to 
short fragments upon Tn5 transposition, ATAC-seq libraries may contain 10–90% of 
mitochondrial reads (Buenrostro et al., 2013; Qu et al., 2015; Montefiori et al., 2016). 
We therefore assessed the content of mitochondrial DNA in our samples derived 
from primary MSCs. The variations between individual donors ranged from 6.0 to 
49.1% (Figure 27A). As indicated in figure 27B, the content of mitochondrial DNA 
between replicates from the same donor was similar. For each donor, the average 
percentage of mitochondrial DNA in the library was plotted against the age of the 
donor. As shown by the coefficients of determination (R2) in figure 27C, there is no 
linear correlation between the percentages of mitochondrial DNA reads in the ATAC-
seq library and donor age (Figure 27C). Thus our dataset indicated that the 
percentages of the mitochondrial reads in the ATAC-seq library vary between donors. 
There was, however, no correlation with donor age. We cannot exclude the possibility 
that under the same in vitro culture conditions, MSCs derived from different donors 
might produce different copy numbers of mitochondria. Follow-up experiments are 
required to further prove this hypothesis.  
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Figure 27 Percentages of mitochondrial reads in sequenced libraries. (A) The percentages of 
mitochondrial reads in ATAC-seq libraries ranged from 6.0% to 49.1%. (B) The percentages of 
mitochondrial reads between replicates derived from the same donor were similar. (C) The average 
percentages of mitochondrial reads are not correlated with the biological age of the donors. R2, 
coefficient of determination between donor age and percentage of mitochondrial reads. 
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4.3.2.4 Open chromatin profiles of MSC-specific marker regions 
 
MSCs are characterized by a combination of cell surface markers (Wagner et al., 
2006). To determine if there are ATAC-seq peak signals at the transcriptional sites of 
these markers, we examined the genome regions encoding these protein markers in 
our ATAC-seq dataset. The transcription start site regions of the positive markers 
were observed in contrast to those of the negative markers which characterize the 
MSCs through their absence (Dominici et al., 2006).  
 
Commonly used positive markers to identify MSCs are CD73 (NT5E), CD90 (THY1) 
and CD105 (ENG). The negative markers are CD45 (PTPRC) and CD34 (CD34). As 
illustrated by the open chromatin profile of one donor (age 21, male), strong ATAC 
seq signals were observed in the transcription start site regions of CD73 and CD90 
suggesting a transcriptional expression of these two genes (Figure 28). For the 
marker CD105, however, a strong signal at the transcription start site was not found. 
The open chromatin profile of the negative marker CD45 showed no peak signal in 
the transcriptional start site region. However, a slightly strong ATAC-seq signal at the 
transcriptional start site region of CD34 was observed (Figure 28). 
 
In conclusion, for the common positive markers of MSCs, peaks at transcriptional 
start sites of CD73 and CD90 were observed. Among the common negative markers 
of MSCs, no ATAC-seq signal was found for the genomic region of CD45. Since 
ATAC-seq only profiles the open chromatin regions of the genome, conclusions on 
gene expression can be only drawn together with information on transcriptomic level 
(e.g. RNA-seq data). Our present dataset defines the open chromatin landscape of 
MSCs. In combination with other phenotypic markers, the open chromatin profiles of 
these marker regions may provide a unique fingerprint for the identification of MSCs 
on chromatin level.  
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Figure 28 ATAC-seq reads mapped to MSC-specific marker gene regions CD73, CD90, CD105 
(positive markers) and CD45, CD34 (negative markers). ATAC-seq data of donor #421 (age 21, 
male) is shown at the corresponding loci on the genome. (A) For the positive markers, peaks at 
transcriptional start sites (TSS) of CD73 and CD90 were observed. No signal was observed at TSS of 
CD105. (B) For the negative markers, no ATAC-seq peak was found at TSS of CD45. A slightly strong 
signal was observed at TSS of CD34. 
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4.3.2.5 Association of age with alterations in chromatin accessibility 
 
The ATAC-seq peaks were determined using the software package MACS2 (Model-
based Analysis of ChIP-seq) with the parameters “-nomodel –q 0.001” (Zhang et al., 
2008). In total 122,884 peaks were identified in the ATAC-seq dataset generated 
from 16 healthy donors (Figure 29).  
To detect significant changes upon aging across sequencing samples, a differential 
peak analysis was carried out using the software package DESeq2 with linear 
regression (Differential Expression Analysis for Sequence Count Data) (Anders et al., 
2012). The null hypothesis that the signal remains unchanged with age was tested. 
Statistical significance was tested according to a Wald test and p-values were 
corrected for multiple testing with Benjamini-Hochberg. At a false discovery rate of 
5%, we could identify 4,579 peaks that changed significantly upon aging (Figure 29). 
Out of this group, 3,050 ATAC-seq peaks decreased with age whereas 1,529 peaks 
increased with age (Figure 29).  
 
Figure 29 A set of 4,579 differential ATAC-seq peaks were identified at a false discovery rate of 
5%. Out of 122,884 ATAC-seq peaks identified in the entire MSC dataset, 4,579 peaks (3.8%) 
changed with age of the donors. Out of this group, 3,050 ATAC-seq peaks (2.5%) decreased with age 
while 1,529 ATAC-seq peaks (1.3%) increased with age.      
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A genomic segmentation of the ATAC-seq peaks totally identified showed that the 
majority of the peaks were found in the intergenic and intron regions (Figure 30A). 
The segmentation of the differential ATAC-seq peaks showed that the majority of the 
peaks were found in the intergenic and intron regions as well (Figure 30B). Using a 
binomial test we found that peaks annotated to promoter-transcription start site (TSS) 
regions were significantly over-represented in the set of differential peaks compared 
to the set of consensus peaks (Figure 30).  
 
Figure 30 Genomic annotation of the consensus and differential ATAC peaks. The majority of the 
ATAC-seq peaks are annotated to the intergenic and intron regions in both (A) consensus and (B) 
differential ATAC-seq peaks. A comparison between consensus and differential peaks showed that 
peaks annotated to promoter-TSS regions are over-represented in the set of differential peaks. 
Abbreviations: 3’ UTR (3’ untranslated region); 5’ UTR (5’ untranslated region); promoter-TSS 
(promoter-transcription start site); TTS (transcription termination site). 
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To determine the relationship between alterations in chromatin accessibility and age, 
we performed a principle component analysis (PCA) on the 500 top variable peaks. 
After corrections for batch effects of the tagmentation enzymes and gender effects of 
the donor, we found that age is associated with the alterations observed in the ATAC-
seq dataset. The first component (PC1) explains 39.1% of the variation between 
samples and separates the youngest (i.e. < age 30) from the elderly donors (age 56, 
57, 59). Under the second component, individuals of age group 30-40 are grouped 
closely to each other; with individuals of age 56 and 57 more distant from individuals 
of age 21 and 23 (Figure 31).  
 
 
Figure 31 Age is associated with the differential peaks in ATAC-seq data. Age of the sample 
donors is indicated by the color code from dark red (21 years) to dark blue (59 years). The first 
component (PC1) explains 39.1% of the variation. The second component (PC2) explains 9% of the 
variation. Image generated by Mariana Ruiz, EMBL HD.   
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4.3.2.6 Functional analysis of differential ATAC-seq peaks upon 
aging 
 
To investigate which category of genes is most likely to change their chromatin state 
upon aging in MSCs, a gene ontology (GO) enrichment analysis was performed on 
the set of 4,579 differential ATAC-seq peaks upon aging. Each peak was assigned to 
the nearest gene on the genome. These peaks on the genome were assigned to 
3,580 genes, with multiple ATAC-seq peaks annotated to the same gene. 
Additionally, an enrichment analysis was performed for pathways of the KEGG 
collection (Kyoto encyclopedia of genes and genomes) (Kanehisa et al., 2000). The 
analysis was performed using the ClueGO plugin in the software Cytoscape, with 
total ATAC-seq peaks detected set as background (Bindea et al., 2009).  
As shown in figure 32, the significantly enriched gene ontology terms for biological 
processes are mostly cell developmental processes such as “nervous system 
development”, “structure morphogenesis” and “multicellular organismal development”. 
The process regulating cell differentiation was also enriched. The enriched terms for 
molecular functions indicated that genes involved in “regulating DNA binding”, “RNA 
polymerase II activity”, “transport across cell membranes” and “protein tyrosine 
kinase activity” are enriched upon aging, suggesting that these cellular processes 
might play critical roles in the natural aging process of MSCs. To determine whether 
the differential peaks upon aging are enriched in specific pathways, we performed an 
enrichment analysis in the pathways of the KEGG collection. The results indicated 
that aging-associated genes are especially enriched in “hippo signaling pathway”, 
“TGF-beta signaling pathways”, and pathways that are typical for cancer cells. The 
hippo signaling pathway and TGF-beta signaling pathway are pathways regulating 
cell proliferation and apoptosis suggesting that these functions might be altered with 
age. The pathway involved in cell-cell adhesion was also found to be altered upon 
aging as well (Figure 32C).  
The results of the enrichment analysis are partially in line with the findings of previous 
studies on aging MSCs (Wagner et al., 2009; Bork et al., 2010). A gene ontology 
analysis on methylation changes upon aging indicated that GO terms “sequence-
specific DNA binding” and “multicellular organismal development” were enriched in 
hypomethylated DNA sites upon aging which agrees with the findings in our ATAC-
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seq data (Bork et al., 2010). Gene expression data suggested that “transcription 
factor activity” and “mesoderm development” enriched in up-regulated genes with 
age (Wagner et al., 2009). Furthermore, TGF-beta/BMP signaling pathways affected 
in aged MSCs (Wagner et al., 2009). Our data on chromatin level suggested that 
pathways involved in cell adhesion, trans-membrane transport and tyrosine kinase 
activity are altered, which might affect the ability of MSCs to function as a stem cell 
niche. These novel findings may serve as a starting point for future follow-up 
validation experiments. 
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Figure 32 Gene ontology (GO) and KEGG enrichment analysis in MSCs. A functional analysis was 
carried out on genes annotated to differential ATAC-seq peaks upon aging. The number of genes 
enriched to each term is represented as percentage of the total number of genes in the term. (A) The 
top five enriched GO-terms of the category “biological processes”. (B) The top five enriched GO-terms 
of the category “molecular functions”. (C) The top five enriched pathways in the KEGG collection. p, p-
value of the enrichment analysis. 
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4.3.2.7 Age-associated ATAC-seq peaks localized in promoter 
regions 
 
To further study the differential ATAC-seq peaks upon aging, we focused on the 
peaks annotated to the promoter-transcription start site region as they are over-
represented in the set of differential peaks. Out of the 4,579 differential ATAC-seq 
peaks, 761 peaks were localized to promoter regions. The most significant peak 
regions (i.e. peaks regions with the lowest p-values) were ranked by their median 
ATAC-seq signal intensity (Supplementary Material Table 4). 
Remarkably, three out of the top four peaks annotated to promoter regions were 
either associated to stem cell proliferative disorders or key metabolic pathways 
(Figure 33).  FGFR1 oncogene partner (FGFR1OP) was reported to be involved in 
several stem cell myeloproliferative disorders (Popovici et al., 1999). TP53-inducible 
glycolysis and apoptosis regulator (TIGAR) is involved in glycolysis and apoptosis of 
the cells (Wanka et al., 2012) and ceramide synthase 6 (CER6) regulates the 
metabolism of ceramides and sphinosines (Peters et al., 2015). Only the biological 
function of tetratricopeptide repeat protein 21B (TTC21B) remains elusive so far. One 
mouse study suggested that TTC21B might contribute to the development of cellular 
cilia (Norris et al., 2012). Figure 33 illustrates the changes of the ATAC-seq peaks in 
the promoter regions of these genes. The dataset shown here was normalized by 
DESeq2 (Differential gene expression analysis based on negative binomial 
distribution).  
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Figure 33 The ATAC-seq peaks localized in the promoter regions of the genes FGFR1OP, 
TIGAR, TTC32B and CERS6 decrease with age of the donor. The ATAC-seq peak signal intensity 
of all donors was plotted against the age of the donor (left). As an illustration, the ATAC-seq profiles of 
MSC samples derived from three individuals of age 21 (upper track), 33 (middle track) and 59 (lower 
track) were compared (right). The total library sizes were normalized. R2, coefficient of determination 
between donor age and normalized read counts; p, p-value of the linear regression between donor 
age and normalized read counts.  
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The FGFR1OP gene can be fused by chromosomal translocation with fibroblast 
growth factor receptor (FGFR1, CD331) which is a receptor tyrosine kinase (Popovici 
et al., 1999). It is a proto-oncogene involved in human cancers as a result of their 
duplication and fusion with other genes (Katoh et al., 2014). In general, the family of 
fibroblast growth factors (FGF) was reported to be involved in the aging of MSCs 
(Wagner et al., 2009). Moreover, it was shown by previous studies that fibroblast 
growth factors appear to promote self-renewal in MSCs while maintaining their 
stemness in vitro (Coutu et al., 2011). As shown in figure 34, some of the direct 
interaction partners of FGFR1OP were also up- or down-regulated with age. 
Interestingly, the chromatin region of tyrosine kinase ABL1 involved in cell 
proliferation, differentiation and apoptosis was more open with age (Khorashad et al., 
2013), along with WRNIP1, the gene encoding the ATPase. WRNIP1 was reported to 
be involved in Werner's syndrome which is characterized by premature aging 
(Kawabe et al., 2006). The gene encoding phosphofurin acidic cluster sorting protein 
1 (PACS1) was up-regulated with age (Figure 34). Mutation of this gene was reported 
to be linked to a rare genetic syndrome characterized by developmental delay 
(Schuurs-Hoeijmakers et al., 2016).    
The gene TIGAR was reported to protect cells from starvation-induced apoptosis by 
up-regulating respiration (Wanka et al., 2012). Furthermore, it was reported that the 
gene P53 induces the expression of a set of antioxidant genes such as TIGAR to 
lower cellular reactive oxygen species (ROS) levels (Feng et al., 2011). 
Biochemically, TIGAR was reported to decrease cellular levels of fructose-2,6-
bisphosphate which is an allosteric regulator of cellular glucose metabolic pathways 
(Bensaad et al., 2006; Madan et al., 2011). Three direct interaction partners of 
TIGAR were found in our mass spectrometry based shot-gun proteomics dataset 
(Figure 34). The tuberous sclerosis 2 gene (TSC2) is a tumor suppressor which is 
associated with the genetic disease tuberous sclerosis (Inoki et al., 2002). The 
amyloid beta precursor protein (APP) is associated to Alzheimer disease. It was also 
reported to modulate neuronal synapse formation (Priller et al., 2006). The ubiquitin-
conjugating enzyme E2 L3 (UBE2L3) is associated with various autoimmune 
diseases as the gene product ubiquitinylates the NF-κB precursor (Lewis et al., 2015). 
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For ceramide synthase 6 (CER6) it was reported that the gene regulates the 
metabolism of ceramides and sphinosines (Peters et al., 2015). Proteins encoded by 
CER6 are integral membrane proteins of the ER that catalyze the synthesis of 
ceramides (Reynolds et al., 2004). In aging MSCs, one previous study reported that 
the ceramide composition of cell membranes is altered upon aging in MSCs (Kilpinen 
et al., 2013). One direct interaction partner of CER6, ATP synthase subunit b 
(ATP5F1), was found to be down-regulated in proteomics dataset (Figure 34). 
ATP5F1 encodes a subunit of mitochondrial ATP synthase (Vaca Jacome et al., 
2015). In conclusion, together with their direct interaction partners, these age-
associated genes identified in our ATAC-seq dataset provide a candidate list for 
future follow-up studies.  
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Figure 34 Network representations of the direct interaction partners of genes FGFR1OP, TIGAR, 
TTC32B and CERS6. Genes identified in the ATAC-seq dataset were shown in orange (up-regulated 
with age) or purple (down-regulated with age). Genes identified in the shotgun mass-spectrometry 
proteomics dataset were shown in pink (up-regulated with age) or green (down-regulated with age).  
 
 
4. Results 
 
105 
 
4.3.2.8 DNA motif enrichment analysis on differential ATAC-seq 
peaks localized in promoter regions 
 
We focused on annotated promoter regions to further analyze which DNA binding 
motifs are differentially accessible between old and young individuals. Among the 
761 peaks annotated to promoter regions, 664 peaks have a negative slope with age, 
suggesting that the promoter regions are more accessible in young individuals, 
whereas 97 peaks are more accessible in aged donors.  
Using a web-based tool AME (analysis for motif enrichment), we wanted to know if 
there is any prevalence of a particular transcription factor binding site in differential 
peak regions compared to consensus peak regions. To this end, a motif enrichment 
analysis on the sequences in differential peaks annotated to promoter regions was 
carried out. The same number of non-differential promoter regions was used as 
control. Four motif databases (homoco v10, jasper 2013, swissregulon human and 
mouse, footprintDB v 1) were used to answer the question, whether there is an over-
representation of the motif in the differential peaks as compared to the control. The 
top five significantly enriched motifs for regions more open in younger individuals are 
binding motifs of the transcription factor AP-2 gamma (TFAP2C), Krueppel-like factor 
16 (KLF16), hypermethylated in cancer 1.p2 (HIC1.p2), Wilms-Tumor-Protein (WT1) 
and metal regulatory transcription factor 1.p2 (MTF1.p2) (Figure 35). TFAP2C is e.g. 
a sequence-specific DNA-binding transcription factor involved in the activation of 
several developmental genes. On the other hand, the motif enrichment in regions 
more open in elderly individuals indicated AT rich motifs that resemble TATA box 
motifs. These are binding motifs of the homeobox C11, A10, C10 and A13 (HOXC11, 
HOXA10, HOXC10 and HOXA13) as well as engrailed homeobox (EN). This finding 
suggests that as the individual ages, TATA box containing promoters are more likely 
to be present as open chromatin region (Figure 35). 
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Figure 35 Ten transcription factor motifs that are enriched in differential promoter regions. (A) 
The top five significantly enriched motifs that are more accessible in old individuals are binding motifs 
of the homeobox C11, A10, C10 and A13 (HOXC11, HOXA10, HOXC10 and HOXA13) as well as 
engrailed homeobox (EN). (B) The top five enriched motifs that are more accessible in young 
individuals are binding motifs of transcription factor AP-2 gamma (TFAP2C), Krueppel-like factor 16 
(KLF16), hypermethylated in cancer 1.p2 (HIC1.p2), Wilms-Tumor-Protein (WT1) and metal regulatory 
transcription factor 1.p2 (MTF1.p2). 
 
Previous studies on transcriptomic and DNA methylation levels showed that the 
expression of many homeobox transcription factors (including HOXA5, HOXB3 and 
HOXB7) as well as genes involved in cell differentiation are changed upon aging 
(Wagner et al., 2009; Bork et al., 2010). Our findings based on ATAC-seq dataset 
confirmed the importance of homeobox transcription factors in aging MSCs. Among 
the transcriptional factors overrepresented in younger individuals, none of the 
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candidates was reported previously to be changing in aging MSCs. However, 
transcription factors such as KLF16 and WT1 are involved in cancer development 
(Yang et al., 2007; Yang, 2009). Remarkably, the MTF1 transcription factor regulates 
the metal homeostasis and oxidative stress, which are important biological process in 
aging (Bahadorani et al., 2010).     
In conclusion, the DNA motif enrichment analysis may serve as a starting point for 
future multi-omics integration efforts. The downstream effects of the aging-associated 
transcription factors described here can be validated and further studied in future 
proteomics and transcriptomics datasets.  
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5. Discussion and Outlook 
 
To study the effects of aging on human bone marrow niche and hematopoietic stem 
cells, 59 bone marrow aspirate samples derived from healthy individuals between 
ages 20 and 60 were collected and characterized by flow cytometry.  
First, I investigated the age-related proportional and morphological changes of the 
major cellular components of the bone marrow comprising of hematopoietic stem 
cells (HSC), lymphocytes and restricted precursors (LYM), monocytes, macrophages 
and restricted precursors (MON), granulocytic precursors (GRA) and erythroid 
precursors (ERP) based on the flow cytometry data obtained during cell sorting.  
The interactions between HSCs and the niche were studied in vitro using a co-culture 
system of HSCs and MSCs. In this set of experiments, the supportive potentials of 
undifferentiated MSCs, adipogenically differentiated MSCs (ADI-MSCs) and 
osteogenically differentiated MSCs (OST-MSCs) for HSCs were explored. The 
proliferation and stemness of CD34+ HSCs were investigated after seven days of co-
culture with these three types of feeder cells.   
We investigated in MSCs the epigenetic changes upon aging using ATAC-
sequencing (ATAC-seq). The ATAC-seq library preparation protocol was adapted for 
primary MSCs. Subsequently, sequencing data were generated from a cohort of 16 
healthy individuals from ages 21 to 59. In this chapter, results obtained from these 
three parts of experiments are discussed. Future perspectives on possible follow-up 
studies are outlined. 
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5.1 Age correlation of changes in relative percentage, cell size and 
granularity of major bone marrow constituents 
 
In our study on the major constituents of the bone marrow, changes observed in 
relative percentage, cell size and granularity are not correlated with the age of the 
donors (Figure 14). These findings are consistent with the previous observations 
made by Bain (Bain, 1996). In that study, bone marrow aspirates in healthy subjects 
were sampled from the iliac crest, 30 men and 20 women, between ages 21 and 56. 
From each individual, about 0.1-0.2 ml of the bone marrow was taken (Bain, 1996). 
The aspirates were subsequently profiled and characterized based on morphological 
traits under light microscope (Bain, 1996). Although using a different method of cell 
characterization, no age-associated correlations in cellular compositions and 
morphological changes were found. However, comparing their results with the 
present study, differences are found in the relative cellular compositions of the bone 
marrow. A summary of the findings published by Bain revealed that the relative 
percentages of ERP, GRA, MON and LYM are around 26%, 37%, 23% and 14%, 
respectively (Bain, 1996). The cell type nomenclature used by Bain was 
approximated to the definitions of the present study. The relative proportions 
obtained in our study showed that ERP constitute to 31.1% of the bone marrow cell 
fraction whereas the relative percentages of GRA, MON, and LYM are 14.8%, 9.9% 
and 29.2%, respectively (Figure 14A). One reason for this discrepancy could be due 
to the different experimental setups. A density gradient centrifugation of the bone 
marrow aspirate was e.g. not performed in the Bain study, which might result into a 
higher percentage of the polymorphonuclear GRA in the total population. In addition, 
the definition of bone marrow cell types solely by a set of morphologic straits also 
leads to differences compared to immunephenotypic identification of cell populations.  
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5.2 Effects of adipogenic differentiation on the supportive potential 
of MSCs 
 
HSCs rely on a cellular microenvironment to maintain their stem cell function. As 
cross-talks with the niche contribute to the regulation of HSC proliferation and 
maintenance of stemness, an in vitro model was developed by co-culturing MSCs 
with CD34+ HSCs. The MSCs serve as a substitution for the cellular environment of 
the niche with their stromal supportive ability.  
We showed that undifferentiated MSCs, adipogenically differentiated MSCs (ADI-
MSCs) and osteogenically differentiated MSCs (OST-MSCs) not only support the 
proliferation of HSCs, but also maintain the CD34 expression in HSCs at a high level 
over a number of population doublings. Remarkably, compared to MSCs and OST-
MSCs, the co-culture with ADI-MSCs increased the proliferation of HSCs much 
stronger while maintaining the HSCs at higher CD34 expression level (Figure 19-21).  
Based on the observations of the co-culture experiments, one can hypothesize that 
ADI-MSCs provide an even better niche for HSCs than undifferentiated MSCs. To 
further prove this hypothesis, however, the relationship between high CD34 
expression and in vivo stemness of the HSCs needs to be investigated. As described 
in the introduction section 1.2.4, previous studies on aged hematopoietic 
compartment showed that despite high expression levels of CD34 in some HSC 
populations, these cells possessed lower in vivo stemness and differentiation 
potential (Geiger et al., 2013). To follow-up on our co-culture experiments, one can 
perform a serial transplantation assay in mouse to functionally study the stemness 
and differentiation potentials of the CD34+ HSCs either co-cultured with ADI-MSCs, 
undifferentiated MSCs or freshly isolated. 
 
Another key issue on the supportive potential of ADI-MSCs is the quantification of the 
differentiation status of ADI-MSCs. On transcriptome level, the expression of several 
transcription regulators such as peroxisome proliferator-activated receptor gamma 
(PPARγ), CCAAT/enhancer binding protein (CEBPα) and fatty acid binding protein 
(FABP) are commonly used markers to characterize the adipogenic differentiation 
(Siersbaek et al., 2010; Polini et al., 2011). Together with BODIPY staining of the 
adipocytic triglycerides, the degree of MSC adipogenic differentiation can be further 
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characterized and related to the effects of ADI-MSCs on the proliferation and 
stemness of HSCs in future experiments.  
 
 
5.3 Influences of the niche on the proliferation and stemness of 
HSCs  
 
Our findings of the co-culture experiment using trans-wells physically separate the 
HSCs from MSCs suggested that direct cell-cell contacts might be required for MSCs 
and OST-MSCs to retain HSCs at a lower proliferation rate (Figure 20). Strikingly, we 
could observe that HSCs cultured in the supernatant of ADI-MSCs showed a similar 
proliferation profile after seven days compared to HSCs grown directly on ADI-MSCs 
(Figure 19, 20).  
Using this experimental setup, the dynamics of the direct versus indirect interactions 
between HSCs and the niche can be investigated by series of time course 
experiments. The HSCs co-cultured on MSCs and differentiated MSCs with or 
without direct cell contacts can be e.g. studied after 12 hours, one day and three 
days. One can speculate here that different mechanisms of interactions come into 
effects at different time points, which might affect the proliferation as well as the 
stemness of HSCs.  
In addition, one could further investigate the immunephenotype of co-cultured HSCs 
using additional stemness marker CD38. The CD34+/CD38- cells represent a more 
primitive HSC subpopulation (Sutherland et al., 1989; Weilbaecher et al., 1991; 
Petzer et al., 1996). By measuring the differentiation markers such as CD13 (myeloid 
differentiation marker), CD45 (general lymphoid marker) and CD56 (markers for 
natural killer cells), one could track the differentiation lineage of the proliferated HSCs 
in relationship with different numbers of cell divisions after seven days of co-culture.  
To further investigate the intrinsic changes in HSCs upon co-culture with different 
feeder cells, gene expression can be profiled by RNA-seq. Chromatin accessibility 
profiles can be generated by ATAC-seq. A combined analysis will uncover changes 
on molecular levels underlying the observed differences in proliferation rate and 
CD34 expression. The findings from in vitro co-culture experiments can be related to 
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the in vivo observations in aged hematopoietic compartment with increased amount 
of adipose tissue (Sudo et al., 2000; Marie, 2014). This will answer the question to 
what extent does the in vitro niche model using adipogenically differentiated MSCs 
reflect the actual aging fatty bone marrow in vivo.  
 
5.4 Variations of HSCs derived from cord and peripheral blood in 
proliferation and stemness upon co-culture  
 
In our experiments, we co-cultured HSCs derived from cord blood and mobilized 
peripheral blood either with MSCs, ADI-MSCs and OST-MSCs. The CD34+ HSCs 
provide a commonly studied population of stem and progenitor cells which can be 
enriched in adequate amount by magnetic cell separation using Dynabeads (details 
in section 3.2.1.2). A comparison between the distributions of proliferated HSCs after 
seven days indicated that cells of both sources showed similar proliferation profiles 
(Figure 19). In both experiments at division steps five and above five, the CD34 
expression level of HSCs co-cultured on ADI-MSCs was the highest (Figure 21). 
However, we found differences between cord and peripheral blood HSCs in relative 
CD34 expression across culture conditions (Figure 21). The observed variations can 
be due to cell-intrinsic properties of the cord and peripheral blood HSCs. It was 
previously shown that HSCs derived from mobilized peripheral blood are less 
adherent to the niche compared to cells derived from cord blood and bone marrow 
(Wagner et al., 2007).  
To further develop the co-culture system, different levels of niche adherence in cord 
and mobilized peripheral blood HSCs can be measured by microscopy-based 
adherence assays (Zepeda-Moreno et al., 2011). This assay quantifies living HSCs 
that lose adhesion due to gravitational force from the MSC feeder cell layer. The 
HSCs are co-cultured with MSCs on a 24-well plate. After an incubation time period 
defined by the experimenter, the plate is turned upside down. HSCs not physically 
attached to the MSCs will fall down. The numbers of the adherent versus non-
adherent HSCs can be determined by microscopy. Using this assay, the fractions of 
adherent and non-adherent HSCs from cord and peripheral blood can be separated 
from each other. The gene expression of these four HSC populations co-cultured with 
MSCs can be profiled to investigate if there are any factors contributing to stemness 
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and adherence. The differences in proliferation rate and stemness between cord and 
peripheral blood HSCs can be related to the variations in niche adherence.  
 
5.5 Integration of different molecular levels to a comprehensive 
regulatory network in MSCs 
 
Integration of chromatin accessibility data with gene expression and protein levels 
leads to deeper understanding of aging MSCs. Among the 16 samples sequenced 
with ATAC-seq, 13 MSC samples were measured by mass-spectrometry proteomics 
method as well (manuscript in preparation, Gavin and Ho lab). The 4,579 differential 
ATAC-seq peaks upon aging were assigned to the nearest 3,580 genes (Figure 36). 
There were 6,509 expressed genes detected on protein level using shotgun 
proteomics (manuscript in preparation, Gavin and Ho lab). A preliminary comparison 
of ATAC-seq and protein data revealed that 1,192 genes were commonly detected 
(Figure 36). To my best knowledge, no direct comparisons between ATAC-seq and 
proteomics data have been done to date. One study on aging CD8+ T cells showed a 
positive correlation between age-related changes in gene expression and chromatin 
accessibility at promoter regions with a correlation coefficient of r=0.34 (Ucar et al., 
2017). One can speculate that the correlation between chromatin accessibility and 
gene expression is higher than the correlation between chromatin accessibility and 
protein level data as transcription is more directly affected by the status of chromatin 
accessibility.  
To obtain a more holistic view on the transcription regulatory landscape in aging 
MSCs, the integration of gene expression data on transcriptome level (e.g. RNA-seq 
data) would be required (Ackermann et al., 2016; Koh et al., 2016). This will help us 
to better interpret our age-associated changes in chromatin accessibility and further 
test our hypotheses generated from our observations in the ATAC-seq dataset.  
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Figure 36 Overview of overlapping genes annotated to ATAC-seq peaks with the proteomics 
dataset. The 4,579 differential ATAC-seq peaks upon aging were annotated to the nearest 3,580 
genes (blue). There were 6,509 genes expressed on protein level detected in the mass-spectrometry 
based shotgun proteomics dataset (red). A set of 1,192 genes was commonly detected in both 
experiments.  
 
5.6 Future perspectives on age-related changes in chromatin 
accessibility of MSCs   
 
The ATAC-seq data on MSCs generated in this study provides a solid foundation for 
future follow-up studies. Further analyses of the data will aim at describing a set of 
common aging features on chromatin level by comparing ATAC-seq profiles of MSCs 
from aged versus young donors. If possible, the number of samples derived from 
aged donors will be further increased to gain more prediction power to build our 
statistical model. The ATAC-seq samples derived from female donors will also be 
increased to obtain a more gender-balanced dataset.  
One aspect worth exploring in future experiments is the commonly described lineage 
skewing of MSCs towards adipogenic differentiation upon aging (section 1.4.4) 
(Stenderup et al., 2003). As chromatin structure undergoes major modifications 
during the differentiation process in stem cells, changes can be captured by 
chromatin accessibility profiling methods such as ATAC-seq (Ramirez et al., 2017). 
By inducing adipogenic and osteogenic differentiation in young and aged MSCs 
during 21 days in vitro culture, the dynamics of chromatin accessibility can be 
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captured at different time points during the differentiation process. The intrinsic 
regulatory mechanisms of the biased differentiation potential towards adipocytes can 
be studied in a time course.  
Focusing on aging, it is of interest to investigate changes in open chromatin profiles 
of the human sex chromosomes. Considering the gender differences in human 
average lifespan, one can speculate that women and men age differently (Austad et 
al., 2016). By studying primary CD4+ T cells isolated from healthy individuals, Qu et 
al. found novel elements that escape X chromosome inactivation and predicted 
gender-specific gene regulatory networks across autosomes (Qu et al., 2015). Using 
our ATAC-seq dataset, gender-specific gene regulatory networks can be further 
investigated in the context of aging.  
Our ATAC-seq data showed that the chromatin regions at certain promoters are open 
and accessible. One recent study identified that the chromatin accessibility profile is 
highly cell-type specific (Corces et al., 2016). Moreover, the accessibility of distal 
elements, such as enhancers, was found to be more cell-type specific than those of 
promoters or patterns of gene expression (Corces et al., 2016). This is probably due 
to the fact that different distal enhancers can regulate the same gene in different cell 
types (Corces et al., 2016). In analogy to this study, one can ask the question if a 
certain group of chromatin region is more age-dependent apart from the promoter 
regions. Corces et al. created an enhancer cytometric atlas using ATAC-seq data 
previously generated from known cell types by a machine learning algorithm. This 
atlas was subsequently used to predict unknown cell types (Corces et al., 2016). In 
analogy, one could try to create an atlas to predict the age of MSCs based on open 
chromatin profiles generated by ATAC-seq. This would serve as a very useful 
diagnostic tool to check the quality of MSCs prior to their clinical applications.   
Due to the supportive function of MSCs for HSCs, one can investigate the changes in 
chromatin accessibility in aged HSCs together with MSCs. Previous studies 
suggested that the methylation pattern in HSCs changes dramatically upon aging 
(Beerman et al., 2010; Bocker et al., 2011). On the chromatin level, another aspect 
would be to study the age-associated changes on chromatin compactness in HSCs, 
as experimental findings suggested that aging leads to a general loss of 
heterochromatin (Booth et al., 2016). This hypothesis can be tested in HSCs using 
ATAC-seq data together with e.g. RNA-seq and proteomics datasets. The MSC-HSC 
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co-culture system serves as an in vitro model to study the effects of the niche on 
stem cells on epigenetic level. Changes in chromatin structures can be captured by 
e.g. co-culturing aged HSCs with young MSCs and vice versa. Thereby it might be 
interesting to explore to what extent the ATAC-seq profile of aged HSCs can be 
“rejuvenated” upon co-culture with young MSCs. Subsequently, the question if age-
associated changes of chromatin accessibility in the niche cells affect the chromatin 
accessibility profiles of HSCs can be addressed.  
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Figure 1 The relative percentages of cell types HSC, LYM, MON, GRA and ERP in the 
mononuclear cell population are not linearly correlated with age of the donor. The numbers of 
the analyzed samples are n=35 for HSC, n=45 for LYM, n=40 for MON, n=44 for GRA and n=45 for 
ERP. The coefficients of determination R2 of the linear correlation test are shown for each cell type. 
ERP, erythroid precursors; MON, monocytes, macrophages and restricted precursors; GRA, 
granulocytic precursors; LYM, lymphocytes and restricted precursors; HSC, hematopoietic stem cells. 
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Figure 2 The relative cell sizes of cell types HSC, MON, GRA and ERP in the mononuclear cell 
population are not linearly correlated with age of the donor. The numbers of the analyzed 
samples are n=33 for HSC, n=40 for MON, n=44 for GRA and n=43 for ERP. The coefficients of 
determination R2 of the linear correlation test are shown for each cell type. ERP, erythroid precursors; 
MON, monocytes, macrophages and restricted precursors; GRA, granulocytic precursors; LYM, 
lymphocytes and restricted precursors; HSC, hematopoietic stem cells. 
 
 
 
 
 
 
 
 
7. Supplementary Material 
 
131 
 
 
Figure 3 The relative cell granularity of cell types HSC, MON, GRA and ERP in the mononuclear 
cell population are not linearly correlated with age of the donor. The numbers of the analyzed 
samples are n=33 for HSC, n=40 for MON, n=44 for GRA and n=43 for ERP. The coefficients of 
determination R2 of the linear correlation test are shown for each cell type. ERP, erythroid precursors; 
MON, monocytes, macrophages and restricted precursors; GRA, granulocytic precursors; LYM, 
lymphocytes and restricted precursors; HSC, hematopoietic stem cells. 
 
 
Table 1 Spearman correlation test of the myeloid to lymphoid ratios with age of the donors. The 
p-values of Spearman's rank correlation were indicated here suggesting a non-correlation of the 
variables with donor age (p-value <0.01). 
myeloid to lymphoid ratio  0.18 
normalized myeloid to lymphoid ratio 0.49 
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Table 2 Spearman correlation test of the relative proportion, cell size, and granularity with age 
of the donors. The p-values of Spearman's rank correlation were indicated here suggesting a non-
correlation of the variables with donor age (p-value <0.01).  
 HSC LYM MON GRA ERP 
Relative proportions 
 
0.95 0.63 0.82 0.02 0.82 
Relative cell size 
 
0.84 N/A 0.28 0.58 0.77 
Relative cell granularity 0.12 N/A 0.29 0.91 0.61 
 
 
Table 3 Gene ontology (GO) and KEGG enrichment analysis. An enrichment analysis was carried 
out on a total set of 3,580 genes annotated to differential ATAC-seq peaks. The ID of the GO-term, the 
term description, the p-value, the percentage of associated genes and the number of genes are 
indicated by the table.  
GO-term Description Term 
p-value 
% of 
associated 
genes 
Number 
of genes 
GO:0007399 nervous system development 5.9E-26 21.6 510 
GO:0009653 anatomical structure 
morphogenesis 
2.5E-21 20.5 523 
GO:2000026 regulation of multicellular 
organismal development 
1.3E-19 21.6 392 
GO:0050793 regulation of developmental 
process 
9.3E-19 20.3 486 
GO:0045595 regulation of cell differentiation 2.5E-18 21.8 353 
GO:0000975 regulatory region DNA binding 1.3E-07 20.7 175 
GO:0000981 RNA polymerase II 
transcription factor activity 
1.9E-07 21.2 156 
GO:0003690 double-stranded DNA binding 2.7E-07 20.7 167 
GO:0022836 gated channel activity 3.2E-07 24.7 83 
GO:0004714 transmembrane receptor 
protein tyrosine kinase activity 
1.1E-06 37.7 26 
GO:0004390 Hippo signaling pathway 1.1E-05 32.2 47 
GO:0005200 Pathways in cancer 4.4E-05 25.8 94 
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GO:0004350 TGF-beta signaling pathway 1.7E-04 35.5 27 
GO:0004510 Focal adhesion 3.6E-04 28.0 52 
 
 
Table 4 The top 50 significant ATAC-seq peaks located in promoter regions ranked by p-value 
as well as median ATAC-seq signal intensity. 
PeakID  P-value Median signal 
intensity 
Gene 
Name 
chr6_167412488_167412988 0 323.4997317 FGFR1OP 
chr12_4430025_4430525 0 284.5970705 TIGAR 
chr2_166810129_166810629 0 181.9555041 TTC21B 
chr2_169312476_169312976 0 157.4173981 CERS6 
chr20_18118279_18118779 0 92.95253727 PET117 
chr3_18486479_18486979 0 74.64841193 SATB1-
AS1 
chr11_17756345_17756845 0 48.35672059 KCNC1 
chr6_166401439_166401939 0 45.50989939 LINC00473 
chr2_47797830_47798814 0 41.98973171 KCNK12 
chr11_117699307_11769980
7 
0 35.27716776 FXYD2 
chr9_27529534_27530034 0 34.14140805 MOB3B 
chr7_8301489_8301989 0 30.35618571 ICA1 
chr3_238823_239323 0 25.48554366 CHL1 
chr3_68981497_68981997 0 22.60781782 FAM19A4 
chr4_3578362_3578862 0 22.18336648 LINC00955 
chr9_68455180_68455680 0 18.42118489 FRG1JP 
chr1_144994687_144995187 0 18.07891226 PDE4DIP 
chr6_62995941_62996441 0 16.32934011 KHDRBS2 
chr4_190579577_190580077 0 16.32934011 LINC01262 
chr7_63505541_63506041 0 10.50791044 ZNF727 
chr11_92702622_92703122 0.000131956 20.09583806 MTNR1B 
chr1_231298130_231298630 0.000134053 29.18864011 TRIM67 
chr12_131355991_13135649
1 
0.000134332 150.0296102 RAN 
chr2_71127513_71128013 0.000141291 91.26859785 VAX2 
chr6_11044326_11044826 0.000158056 30.0150118 ELOVL2 
chr22_34316954_34317454 0.000163652 169.2844816 LARGE 
chr3_12329296_12329796 0.000185944 29.87373204 PPARG 
chr11_57227851_57228351 0.000199059 29.10231199 RTN4RL2 
chr17_38574020_38574520 0.000211472 96.80965922 TOP2A 
chr11_115630573_11563107
3 
0.000248984 25.60605604 LINC00900 
chr20_29611600_29612100 0.000266491 65.37872211 FRG1BP 
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chr12_9217103_9217603 0.000284935 60.12859862 LINC00612 
chr1_6480542_6481042 0.000284935 17.49572154 HES2 
chr20_17207223_17207723 0.000293714 37.94523214 PCSK2 
chr11_115374977_11537547
7 
0.0003215 52.07581907 CADM1 
chr7_158497441_158497941 0.000359942 309.6742713 NCAPG2 
chr9_103189251_103189751 0.000396524 58.32490542 MSANTD3 
chr20_33759525_33760025 0.000460685 92.76361948 PROCR 
chr3_192958713_192959213 0.000468462 57.79350741 HRASLS 
chr6_146864518_146865018 0.000469786 282.2643076 RAB32 
chr17_46018600_46019100 0.000481451 81.08584411 PNPO 
chr7_73038649_73039149 0.000490928 23.01707925 MLXIPL 
chr12_44199888_44200388 0.000494501 98.22030298 TWF1 
chr2_14772516_14773016 0.00051887 132.2979562 FAM84A 
chr2_211341234_211341734 0.000525976 135.4352901 LANCL1 
chr10_123356608_12335710
8 
0.000617643 14.56316781 FGFR2 
chr7_86688723_86689223 0.000620645 61.23502541 KIAA1324L 
chr6_90121699_90122199 0.000628877 25.464523 RRAGD 
chr1_211307313_211307813 0.000635654 132.5164261 KCNH1 
chr7_3340439_3340939 0.000635654 93.40364835 SDK1 
 
 
